Key Takeaways
Why is 0G facing further downside risk?
Technical indicators like MFI at 30 and RSI below 50 suggest weakening momentum, signaling bearish pressure on 0G.
Who is driving the recent 0G market decline?
Perpetual traders dominate the derivatives market, with $18.3 million exiting and a negative OI-Weighted Funding Rate of -0.0879%.
0G [0G] stumbled in the past 24 hours. The asset, which had been forming new highs, now faces the threat of further decline after losing 21%, at press time.
Trading volume also fell, dropping to around half a billion—precisely $512 million—showing that weak hands are exiting the market.
How this plays out for 0G remains uncertain, according to AMBCrypto’s analysis.
Support level reached
The 1-hour support level analysis shows that 0G has taken a sharp drop after recently setting a new high.
This drop does not necessarily mark the beginning or end of a broader decline, as the chart indicates it coincides with a key support zone.
Source: TradingView
This level has been instrumental in 0G’s previous rallies, with one of the latest instances leading to the $0.34 high on the 23rd of September.
If it holds, a possible push forward could occur, similar to past scenarios when the token traded along this level.
The big question: Will 0G maintain its bullish momentum and push higher from here?
Support level may be a trap
However, the support level could prove a trap for investors expecting a rebound, turning into a bull trap. Technical indicators lean bearish.
At press time, the Money Flow Index (MFI), which tracks liquidity flowing in and out of an asset, fell to 30, entering bearish territory below the neutral 50 mark. This drop indicates growing bearish sentiment among investors.
The Relative Strength Index (RSI) also points to potential downside, slipping just below the bullish threshold to 49, signaling weakening momentum.
Source: TradingView
If both indicators continue trending lower, they would confirm that the support level may fail to spark an upward push, triggering liquidations for long traders.
Presently, liquidation data shows $2.87 million in long contracts closed compared to $874,000 in shorts—a clear sign the market is leaning bearish.
Blame the perpetual investors
If any group of investors is responsible for the recent drop, it is perpetual traders. Over the past days, $18.3 million worth of 0G exited the market, while Open Interest (OI) fell to $81.13 million, as of writing.
This decline in OI alone does not confirm whether bulls or bears control the market—it only shows a reduction in contractual value.
Source: CoinGlass
However, the OI-Weighted Funding Rate turning negative confirmed bearish dominance.
A rate of -0.0879% implies that most liquidity in the derivatives market comes from bears, suggesting the market may continue trending downward.
2025-09-26 08:555mo ago
2025-09-26 04:005mo ago
Bitcoin On The Brink: Analyst Warns This Key Level Must Hold
Crypto analyst Kevin (Kev Capital TA) told viewers late on September 25 that Bitcoin’s pullback is tracking a familiar seasonal and structural script—and that the market’s next major impulse hinges on a clearly defined support range. “Hold $107k to $98K,” he said, calling the zone the fulcrum for the bull cycle’s next leg. “That’s it. It’s that simple.”
Opening his stream amid a rush of bearish sentiment as BTC price dipped to $108,651, Kevin argued the drawdown should not surprise disciplined traders. He framed the current move in the context of months of caution dating back to early August, when he began highlighting weekly bearish divergences across Bitcoin, Ethereum and the total altcoin market (Total2), into what he described as four-plus-year resistance zones.
“Everyone thinks these symmetrical triangle patterns after a move higher are continuation patterns,” he said, “but in reality, in the crypto market, very, very rarely do these break out to the upside.” He pointed to a progression of smaller impulse highs since late 2023 and reiterated that despite sharp rallies in select altcoins, the majors failed to clear “any major resistance levels.”
Bitcoin Top In Until Proven Otherwise
The anchor of Kevin’s case is confluence on higher time frames. On Bitcoin’s weekly chart, he outlined rising price highs against falling momentum—“simple strength and momentum indicators,” not signals by themselves but context that “has been dwindling for a very long time.”
Total2, he added, registered “a triple top on the weekly” beneath roughly $1.71–$1.74 trillion—“the all-be-all resistance level”—with weekly RSI and MACD rolling over. Stocks of momentum, in his read, are resetting precisely where they should amid historically thin late-summer liquidity. “Q3 is never a good quarter for crypto,” Kevin said. “August, September are terrible months. They always are.”
TOTAL2 market cap analysis | Source: X @Kev_Capital_TA
Against that backdrop, he argued that USDT dominance remains the most reliable inter-market compass. “USDT dominance is the greatest chart ever. There is no better chart,” he said, walking through a macro descending triangle with a flat-bottom support near 3.9–3.7% and repeated rallies to a falling trendline that have mapped crypto cycle lows and highs for two years.
Each approach to the flat bottom, he noted, has carved a W- or inverse-head-and-shoulders-style base in USDT.D while Bitcoin distributed near local tops; each rejection at the downtrend has coincided with crypto inflections. “You literally don’t need any chart in all of crypto,” he said. “All you need is Bitcoin and USDT dominance and you would have played this cycle absolutely perfectly.”
USDT dominance chart | Source: X @Kev_Capital_TA
From a tactical standpoint, Kevin flagged a three-month BTC liquidity “heat map” shelf near $106.8K and the 21-week EMA—the bull-market support band—near $109.2K as natural magnets, with the lower weekly Bollinger Band sitting around $101K.
He stressed he doesn’t want to see “Bitcoin lose 106.8K” if the cycle remains intact, though a wick into that area to “swipe the liquidity” would be consistent with prior resets. He framed $98K as the line that should not break decisively. “There’s a whole lot of support in that range,” he said. “I’d be pretty shocked if Bitcoin wasn’t able to bounce in there somewhere.”
All Eyes On Q4 Seasonality
Kevin tied structural signals to an explicit macro checklist, arguing that lasting cycle tops and bottoms align with fundamental catalysts rather than charts alone. He cited 2021’s inflation spike and the onset of the Fed’s hiking cycle as the driver of that cycle’s 55–60% drawdown, the 2017 CME Bitcoin futures launch as a blow-off top catalyst, and the FTX collapse as the final capitulation in 2022 amid weekly bullish divergence.
“There’s always a macro-related reason that correlates with the charts,” he said. By contrast, he sees no such cycle-ending macro trigger today: inflation gauges have been “very choppy” but contained; the Fed is widely expected to ease into year-end provided labor softens; and seasonality favors Q4.
He underscored the near-term calendar—core PCE, CPI and labor data in the first half of October—as decisive for risk appetite. “Sometime in mid-October… we’ll start to have an idea of where this market is really going to go,” he said. “If we get to mid-October and Bitcoin’s holding key support… and we get good macroeconomic data, we get another rate cut… the probabilities favor that Bitcoin will [go higher]—and then you’re in Q4.”
Volatility positioning, he added, argues for a sharp directional move once the reset completes. On the weekly Bollinger Band Width, Kevin said BTC has printed record-low readings three times this cycle—each in Q3—and each episode began with a downside break of 18–29% before surging to fresh highs.
“There is a massive move coming for Bitcoin soon. It has not happened yet,” he said, noting spot volumes have declined since November while bands have tightened to historic extremes. A test of the lower weekly band near $101K “is possible,” but not required, in his view; the key is that the broader $107K–$98K corridor functions as a springboard.
Kevin was equally explicit about invalidation and upside triggers. He labeled $125K “a major top for now” and said the market needs weekly and monthly closes above that level to confirm trend continuation.
On dominance, he highlighted 59.0% and 60.28% as near-term resistance that could fuel a BTC-led phase if reclaimed; otherwise, he expects leadership to rotate back to altcoins once Bitcoin bases and USDT dominance prints a lower high. “Stop looking at the altcoins” until those inter-market signals flip, he advised, emphasizing patience, risk management and taking profits into resistance.
His bottom line combines restraint with opportunism. “Hold $107k to 98K,” he repeated. “Go into October. Get through the first couple of weeks of macroeconomic data… Bitcoin will inevitably find a low on the back of that data and then eventually go higher.” But he warned that if macro arrives benign and “Bitcoin is still deteriorating,” traders should be ready to reassess the cycle thesis. Until then, Kevin’s message remains unapologetically unglamorous: respect the seasonal chop, track the inter-market tells, and let the higher-time-frame levels do the talking. “Being right is the best pat on the back you can get,” he said. “Not just saying things that get you a lot of clicks.”
At press time, BTC traded at $109,607.
BTC fell below key support, 1-day chart | Source: BTCUSDT on TradingView.com
Featured image created with DALL.E, chart from TradingView.com
The stock prices of Bitcoin-holding companies that used PIPE programs are falling.This creates a negative feedback loop: low Bitcoin price, falling stock values, and more selling.A sustained Bitcoin rally is the only catalyst that can break this vicious cycle.The stock prices of Digital Asset Treasury (DAT) companies that acquired Bitcoin as a strategic asset are in significant decline, raising the possibility of a new headwind for Bitcoin’s price.
According to a new report from on-chain data platform CryptoQuant, a continued weak performance in Bitcoin’s price could create a negative feedback loop.
What Is a PIPE?
CryptoQuant’s report focuses on Bitcoin holding companies that have raised capital through Private Investment in Public Equity (PIPE) programs. The firm’s analysis of these companies’ stock performance found a significant downtrend.
Sponsored
Sponsored
A PIPE is a private offering where a public company sells newly issued shares (or convertible securities) to a select group of accredited or institutional investors. This method allows a company to raise capital quickly by selling shares at a discount to the market price.
Many Bitcoin DAT companies raised capital this year. The method’s key disadvantage—that it dilutes existing shareholders and puts downward pressure on the stock price—was largely ignored due to Bitcoin’s strong upward trend at the time. CryptoQuant notes that Bitcoin firms that used PIPE programs have since experienced significant drops in their stock prices.
Vicious Cycle of Decline
For example, Kindly MD (NAKA), a Bitcoin DAT company, saw its share price surge from $1.88 in late April to a high of $34.77 in less than a month—an 18.5x increase. However, the stock has since plummeted by 97% to a low of $1.16 and is currently trading near its PIPE price of $1.12.
NAKA stock price and PIPE price. Source: CryptoQuant
CryptoQuant explained that other Bitcoin trust companies, including Strive (ASST), Cantor Equity Partners (CEP), and Empery Digital (EMPD), have seen their stock prices fall between 42% and 97%. Some stocks still trading above their PIPE issuance prices face a potential for up to an additional 50% decline.
While these DAT companies may have accumulated a large amount of cryptocurrency, their market valuation is falling even faster. This trend is seen in the rapid decline of their Market Value to Net Asset Value (mNAV).
Domino Effect
As Bitcoin’s price remains weak, the stock prices of DAT companies fall. This decline leads to selling by PIPE investors. If continues, companies may lose their primary method of raising additional operating capital, leaving their only option to sell their Bitcoin holdings for cash.
This would put more downward pressure on Bitcoin’s price, creating a vicious cycle in which Bitcoin’s price and DAT company stocks fall in tandem. CryptoQuant argues that a sustained Bitcoin rally is the only catalyst to prevent further decline in these stocks. Without such a move, the firm’s analysts believe many crypto equities will continue to fall toward or below their PIPE prices.
Disclaimer
In adherence to the Trust Project guidelines, BeInCrypto is committed to unbiased, transparent reporting. This news article aims to provide accurate, timely information. However, readers are advised to verify facts independently and consult with a professional before making any decisions based on this content. Please note that our Terms and Conditions, Privacy Policy, and Disclaimers have been updated.
2025-09-26 08:555mo ago
2025-09-26 04:215mo ago
Bitcoin Selloff Deepens as Options Expiry and Inflation Test Loom
Bitcoin struggles near monthly lows after a wave of liquidations, with options expiry and U.S. inflation data fueling uncertainty.
Published:
September 26, 2025 │ 8:00 AM GMT
Created by Kornelija Poderskytė from DailyCoin
More than $1 billion in leveraged positions were wiped out this week as Bitcoin tumbled toward $109,000, setting the stage for one of the market’s most volatile periods of 2025.
With $22 billion in crypto options contracts expiring on Friday and a key U.S. inflation report due the same day, traders say Bitcoin is at a critical crossroads.
Sponsored
On Thursday, Bitcoin (BTC) slid to $108.7K, its weakest level in nearly a month, before steadying just above $109K threshold.
Ethereum (ETH) tumbled even more in 24 hours to around $3,800, extending its losses to 14.3% since last month’s record highs.
The declines triggered a broad leverage flush. Data from CoinGlass shows that more than $975 million in liquidations occurred, led by $312 million in wiped ETH longs and $247 million in BTC.
Source: CoinGlassCrypto equities mirrored the slump. MicroStrategy (MSTR), the largest corporate holder of Bitcoin, fell as much as 10% to a five-month low, erasing its 2025 gains. Shares of miners Marathon Digital (MARA) and Riot Platforms (RIOT), along with Ether treasury firms Bitmine (BMNR) and Sharplink Gaming (SBET), slid 7–8%.
The selloff comes just as the market braces for the expiration of $22.3 billion in crypto options contracts on Friday. According to Deribit, a crypto options exchange, this is one of the biggest quarter-end expiries.
🚨 Options Expiry Alert 🚨
At 08:00 UTC tomorrow, over $22.3B in crypto options expire on Deribit; one of the biggest quarter-end expiries. 🔥$BTC: Notional: $17.06B | Put/Call: 0.76 | Max Pain: $110K$ETH: Notional: $5.20B | Put/Call: 0.80 | Max Pain: $3,800
Q3’s largest… pic.twitter.com/FDT1tWomYH
— Deribit (@DeribitOfficial) September 25, 2025
More than $17 billion is tied to Bitcoin, with dealer positioning clustered around $108,000–$109,000. A decisive break lower could force hedging flows that accelerate losses toward $96,000.
Macro risk adds another layer. The U.S. Core PCE report, a key Federal Reserve inflation gauge, is expected to show a slight cooling, but an upside surprise could strengthen the dollar and deepen the selloff across risk assets.
Still, not all signals point bearish. Meanwhile, crypto traders urge investors to zoom out to higher timeframes, which they say remain “unequivocally bullish,” describing the current pullback as a normal, healthy correction in a broader context.
According to @CredibleCrypto, the decline should either hold above the $98,000 lows — a pattern known as a “running flat” — or briefly dip below them in what’s called an “expanded flat.” In both scenarios, he said, the higher-timeframe structure remains intact.
Zooming out to remind you all of where we are in the bigger picture so you don't get lost in the lower timeframes and panic un-necessarily:
High timeframes remain unequivocally bullish, and the current correction is considered normal/healthy in HTF context.
The idea shared… https://t.co/y1ydqUy3IG pic.twitter.com/uVBDN2iSFz
— CrediBULL Crypto (@CredibleCrypto) September 25, 2025
Why This MattersThe convergence of forced liquidations, record options expiry, and pivotal macro data threatens to break Bitcoin’s critical support, which could set the tone for crypto markets into the fourth quarter.
Read DailyCoin’s most popular crypto news:
Celestia’s Matcha Magic Kicks In With Huge Inflation Cut
Bitcoin’s Calm Before the Storm? $105K Support Faces Test
People Also Ask:Why did Bitcoin’s price drop this week?
Bitcoin fell after a sharp selloff in crypto markets triggered more than $975 million in liquidations.
What are crypto liquidations?
Liquidations occur when leveraged traders can’t meet margin requirements. Exchanges automatically close their positions, which often amplifies price swings.
What is the options expiry, and why does it matter?
Options expiry refers to contracts reaching their settlement date. Large expiries can increase volatility as traders and dealers rebalance their positions.
What role does U.S. inflation data play in Bitcoin’s price?
The Core PCE inflation report influences Federal Reserve policy. A hotter reading could boost the dollar and pressure risk assets, including Bitcoin.
Are traders still bullish on Bitcoin long-term?
Yes. Some analysts see the pullback as a healthy correction within an intact bullish trend, expecting higher prices later in 2025.
This article is for information purposes only and should not be considered trading or investment advice. Nothing herein shall be construed as financial, legal, or tax advice. Trading forex, cryptocurrencies, and CFDs pose a considerable risk of loss.
2025-09-26 08:555mo ago
2025-09-26 04:235mo ago
Pi Network Founders Defend Vision as Pi Price Plunges in Late September
Pi Network founders urged long-term focus, presenting Pi as a crypto, social network, developer platform, and utility-driven ecosystem.Ecosystem initiatives include App Studio, enabling grassroots app creation, and Pi Ventures, a $100 million fund supporting disruptive teams.Despite Pi Coin’s 50% plunge, leaders stress KYC progress, infrastructure scaling, and building real-world adoption beyond short-term volatility.Pi Network founders stepped onto a stage in Seoul to remind the community of their long-game vision.
Their debut came even as the Pi Coin price slid by more than 50% in late September.
Pi Network Founders Highlight Achievements Amid Ecosystem ExpansionSponsored
Sponsored
Nicolas Kokkalis (NK) and Chengdiao Fan (Cfan), co-founders of Pi Network, addressed Korean pioneers at a local meetup.
They reaffirmed Pi’s mission to prioritize utility, community growth, and ecosystem development over short-term market volatility.
Fan outlined Pi’s multi-layered identity at the event, presenting it as more than crypto. According to the Pi Network executive, it is a developer platform, social network, and utility-driven ecosystem.
He emphasized the scale Pi has already achieved, citing 60 million engaged mobile users, 350,000 testnet nodes ready for mainnet, and over 14 million users who have completed KYC verification.
“Pi is a lot of things…We are a cryptocurrency, a social network, a developer platform, and a utility-focused ecosystem… Our next stage is continuing to expand the community and ecosystem, emphasizing utility and going beyond,” Fan said.
One of Pi’s newest initiatives is App Studio, an AI-powered tool that enables non-technical users to build and deploy apps within the Pi ecosystem.
Thousands of apps have reportedly already been created in its first three months, and the founders see this as a cornerstone of future growth.
Sponsored
Sponsored
Complementing grassroots creativity, Pi also unveiled Pi Ventures, a $100 million fund designed to back high-potential, disruptive teams aligned with its vision.
Long-Term Vision Over Market Cycles
The founders also urged the community to look past short-term fluctuations. This remark came as they addressed Pi coin’s turbulent token price and widespread speculation about unofficial exchange listings.
In this regard, Kokkalis reflected on Pi’s humble beginnings, when he and Fan struggled to recruit even 54 early adopters in a shopping mall.
“For me, it’s really the community. We started more than seven years ago with just a vision, and despite challenges, we stayed focused on building utility and adoption,” Kokkalis said.
Sponsored
Sponsored
Fan added that true value creation takes time, warning that crypto’s value extraction culture often overshadows the harder task of building real-world use cases.
“Long-termism really needs to kick in. Value creation is always harder than value extraction,” he said.
Tackling Challenges Like KYC, Infrastructure, and Trust
The founders also addressed key community concerns. They clarified that only Pi listed on officially recognized KYB-approved exchanges should be considered legitimate.
The Pi Network executives warned against scams and unauthorized tokens in this regard.
Fan noted that Pi’s unique approach to KYC, which has already onboarded millions without out-of-pocket fees, is critical for ensuring ownership and compliance in a global network.
Sponsored
Sponsored
This observation comes barely a week after the ecosystem eased the KYC bottleneck with a new feature. In hindsight, Pi Network KYC was a contentious issue, with users citing transparency, migration delays, and price volatility, among other concerns.
On infrastructure, Kokkalis acknowledged the technical challenges of scaling to tens of millions of daily users, far beyond the capacity of typical blockchain projects.
Despite market skepticism, the co-founders painted a picture of Pi as a platform positioned for mass adoption, bridging blockchain and AI to deliver practical tools and services.
With grassroots app creation, a major venture fund, and a growing global community, they argue Pi is building a foundation designed to outlast short-term volatility.
“We insist on utility because blockchain networks must produce products that are actually useful and address human needs. That is how real adoption happens,” Fan concluded.
Pi Network (PI) Price Performance. Source: BeInCrypto
As of this writing, Pi Network’s token, Pi Coin, was trading for $0.2616, down by almost 4% in the last 24 hours.
Disclaimer
In adherence to the Trust Project guidelines, BeInCrypto is committed to unbiased, transparent reporting. This news article aims to provide accurate, timely information. However, readers are advised to verify facts independently and consult with a professional before making any decisions based on this content. Please note that our Terms and Conditions, Privacy Policy, and Disclaimers have been updated.
2025-09-26 08:555mo ago
2025-09-26 04:265mo ago
Bitcoin sees most fear since $83K as analysis eyes ‘turning point'
Crypto sentiment gauge, the Crypto Fear & Greed Index, collapsed below 30/100 for the first time since mid-April, with Bitcoin trading $25,000 higher.
332
Key points:
The Crypto Fear & Greed Index is back at levels not seen since Bitcoin traded at $83,000.
Analysis wonders whether the BTC price “turning point” is already here.
Social media user behavior already suggests that a price rebound should take place next.
Bitcoin (BTC) sentiment collapsed overnight Thursday as the latest BTC price dip forced fresh liquidations.
Fresh data from the Crypto Fear & Greed Index shows that “fear” now drives the mood.
Bitcoin sentiment echoes April lowsBitcoin, nearing new monthly lows under $109,000, had a near-instant impact on market sentiment.
The Fear & Greed Index, which lags market movements, hit just 28/100 on Friday, marking its lowest levels since April 11. The index fell 16 points in a single day.
Crypto Fear & Greed Index (screenshot). Source: Alternative.me“MORE fear and a HIGHER price,” crypto YouTube channel host Michael Pizzino summarized in part of an X post on the topic.
Pizzino referred to the emerging divergence between price and sentiment.
The last time that the Fear & Greed Index was below 30/100, BTC/USD traded at around $83,000, days after its recovery from $75,000 lows, data from Cointelegraph Markets Pro and TradingView confirms.
BTC/USD one-day chart. Source: Cointelegraph/TradingView
As a result, accompanying analysis argues that the time is right for a market reversal.
“Could this be the turning point Bitcoin and Crypto has been waiting for? The analysis looks good, but it has not been confirmed,” Pizzino added.
BTC/USDT perpetual contract one-day chart with sentiment data. Source: Michael Pizzino/XFear & Greed has been no stranger to erratic moves in 2025. As Cointelegraph reported, in February, the Index collapsed to just 10/100 thanks to macroeconomic uncertainty focused on US trade tariffs.
“Impatience and bearishness” rule BTC price takesSome signals of an impending BTC price rebound emerged even before the latest dip.
On Tuesday, research platform Santiment showed that social media users were already convinced that lower prices would soon come.
“As usual, social media is vocal on where Bitcoin will head next. Historically, lower price predictions increase the likelihood, and higher predictions imply lower future prices,” it explained to X followers.
Santiment described a “high amount of impatience and bearishness emerging from the retail crowd.”
At the same time, data revealed that large-volume traders were adding exposure in recent days.
Bitcoin price social media activity data. Source: Santiment/XThis article does not contain investment advice or recommendations. Every investment and trading move involves risk, and readers should conduct their own research when making a decision.
2025-09-26 08:555mo ago
2025-09-26 04:295mo ago
Plasma (XPL) Price Analysis – Is the Hype Sustainable?
Plasma’s native token XPL has been the talk of the market over the past 24 hours. Despite broader crypto uncertainty, XPL surged to an all-time high of $1.43 before cooling to $1.28, down 2.1% on the day. What makes this move fascinating is that it happened in the middle of a red market, where most altcoins struggled to hold gains. With a market cap now standing at $2.23 billion and 24-hour trading volume exploding by more than 355,000% to $6.77 billion, Plasma is forcing everyone to pay attention.
The token’s sudden rise isn’t just about speculation. It’s backed by one of the strongest viral launches we’ve seen in months, combined with a unique utility: gasless USDT transfers. Let’s break down the factors fueling this run and what’s next for XPL.
XPL’s price journey in the past day has been nothing short of dramatic. The token bottomed out at $0.6923 just 18 hours ago before mooning to $1.43, its ATH, in less than a day. This 100%+ rally in under 24 hours was triggered by a mix of fundamentals and hype.
Source: CoinMarketCapAt the core of Plasma’s appeal is its mainnet beta, which went live on September 25. Within just one hour, the network secured $250 million in locked USDT, proving demand for zero-fee stablecoin transfers. Unlike other blockchains, Plasma’s pitch is simple: send and receive USDT without paying gas fees, something retail traders and whales alike find irresistible.
The viral factor can’t be ignored either. A 10% airdrop of the total supply, now valued at over $1.2 billion, gave early adopters life-changing returns. Every depositor received a flat $10k allocation, with presalers now sitting on 200x+ profits. Add Cobie’s social media backing, exchange listings on KuCoin, OKX, and Gate.io, plus the launch of leveraged futures, and you get the perfect storm of FOMO and liquidity.
Still, after such a vertical move, a short-term pullback was inevitable. The price slipping to $1.28 suggests traders are locking in profits, but strong trading volume shows fresh demand remains. If momentum continues, retesting the $1.43 ATH or even higher isn’t off the table. Conversely, a dip below $1.10 could signal deeper consolidation.
FAQsWhy did XPL price pump so hard?
Because of its viral airdrop, gasless USDT transfers, top exchange listings, and heavy hype.
Is Plasma’s rally sustainable?
Short-term volatility is likely, but strong utility and adoption give it longer-term potential.
What’s the biggest risk for XPL right now?
Profit-taking by early airdrop winners and over-leveraged futures trading could trigger sharp dips.
2025-09-26 08:555mo ago
2025-09-26 04:305mo ago
OKB Defies Market Slump—But Can It Break $200 This Month?
OKB price surged nearly 10% in 24 hours with trading volume spiking 200%, signaling strong buyer conviction over speculation. Trading above its Super Trend line at $169.35, OKB shows bullish momentum with potential to test resistance at $196.84. A breakout could drive OKB toward $210, but profit-taking risks may trigger pullbacks to $173.69 or deeper to $169.35 support.OKB has emerged as one of the strongest performers in the market, climbing nearly 10% in the past 24 hours. This comes as Bitcoin and other leading digital assets trade lower, pushing the global crypto market cap down by 2%.
On-chain data shows rising demand for OKB, and if this momentum holds, the altcoin could close September above the key $200 level.
Sponsored
Sponsored
OKB Rally Builds Steam
OKB’s price rally comes amid a notable spike in demand, with its daily trading volume surging almost 200% in the past day. This totals $293 million at press time, suggesting that the rally is not driven by speculation.
For token TA and market updates: Want more token insights like this? Sign up for Editor Harsh Notariya’s Daily Crypto Newsletter here.
OKB Price/Trading Volume. Source: Santiment
When an asset’s price rises alongside a sharp increase in trading volume, it signals strong conviction among buyers rather than short-term hype.
Higher volumes mean more market participants are involved in the move, lending credibility to OKB’s rally and reducing the risk of a quick reversal. If demand continues at this pace, the increased depth in the market could provide the support needed for OKB to test the $200 level.
Further, readings from the daily chart show that OKB trades solidly above its Super Trend Line, reflecting a strong bullish tilt in market sentiment. At press time, this indicator forms dynamic support below OKB’s price at $169.35.
OKB Super Trend Indicator. Source: TradingViewSponsored
Sponsored
The Super Trend indicator tracks the market’s direction by placing a line above or below the price chart based on the asset’s volatility.
As with OKB, when an asset’s price trades above the Super Trend line, it signals a bullish trend. It highlights that the market is in an uptrend that may persist as buying pressure dominates.
OKB Bulls Target $210, Yet Profit-Taking Threatens a Pullback
As September nears its close, all eyes are now on whether this momentum will be enough to propel the token toward the $200 milestone. For that to happen, OKB must first break above its next major resistance, which lies at $196.84.
A successful breach of this level could propel its price toward $210.57 in the near term.
OKB Price Analysis. Source: TradingView
However, a surge in profit-taking would invalidate this bullish outlook. In that scenario, OKB could shed some of its recent gains and test support at $173.69.
OKB could fall toward the dynamic support of its Super Trend line at $169.35 if this level gives way.
Disclaimer
In line with the Trust Project guidelines, this price analysis article is for informational purposes only and should not be considered financial or investment advice. BeInCrypto is committed to accurate, unbiased reporting, but market conditions are subject to change without notice. Always conduct your own research and consult with a professional before making any financial decisions. Please note that our Terms and Conditions, Privacy Policy, and Disclaimers have been updated.
2025-09-26 08:555mo ago
2025-09-26 04:305mo ago
Bitcoin Cycle Inflows Hit $678 Billion: How Do Past Cycles Compare?
Trusted Editorial content, reviewed by leading industry experts and seasoned editors. Ad Disclosure
On-chain data shows Bitcoin inflows this cycle have totaled to $678 billion. Here’s how this figure compares with that of the previous cycles.
Bitcoin Realized Cap Growth Has Been 1.8x Larger Than Last Cycle
In its latest weekly report, on-chain analytics firm Glassnode has discussed about the growth in the Realized Cap of Bitcoin. This capitalization model calculates BTC’s total value by assuming that the value of each token in circulation is equal to the price at which it was last transacted on the blockchain.
The last transaction of any token is likely to correspond to the last time at which it changed hands, so the price at its time could be considered as its current cost basis. As such, the Realized Cap is essentially the sum of the cost basis of the entire BTC circulating supply.
In other words, the model represents the total amount of capital that the investors used to purchase their Bitcoin. This is in contrast to the usual market cap, which is instead the value that holders are carrying in the present.
In the current cycle so far (starting in November 2022), the Realized Cap has jumped in three big waves, suggesting a large amount of capital has flowed into BTC through three phases. Following the latest inflows, the indicator has risen to a record $1.06 trillion, as the below chart shows.
How the metric's value has changed over the course of the asset's history | Source: Glassnode's The Week Onchain - Week 38, 2025
But how much of the capital stored in Bitcoin came in during the latest cycle alone? Another chart shared by Glassnode in the report breaks it down for not just this cycle, but also all past ones.
BTC's cycles stacked up against each other in terms of the Realized Cap trend | Source: Glassnode's The Week Onchain - Week 38, 2025
In total, an unprecedented $678 billion in capital inflows have come into Bitcoin during the latest cycle. This is 1.8 times the $383 billion in Realized Cap growth that the 2018 to 2022 cycle witnessed. The last cycle saw a more exponential jump from the previous ones ($4.2 billion from 2011 to 2015, and $85 billion from 2015 to 2018), but the sheer scale of capital involved in the latest cycle is still quite impressive.
Besides the rise in the Realized Cap, another metric that the current cycle stands out in is the Realized Profit/Loss Ratio. This indicator measures, as its name implies, the ratio between the amount of BTC being shifted at a profit and that at a loss.
The data for the Realized Profit/Loss Ratio over the years | Source: Glassnode's The Week Onchain - Week 38, 2025
As is visible in the above chart, the Bitcoin Profit/Loss Ratio has seen three peaks with extreme values in this cycle, which is unlike the single prolonged waves from the previous cycles. “Having just stepped away from the third such extreme, probabilities favour a cooling phase ahead,” explains the analytics firm.
BTC Price
Bitcoin has seen its drawdown deepen over the past day as its price has dropped to the $109,300 level.
The trend in the BTC price over the last five days | Source: BTCUSDT on TradingView
Featured image from Dall-E, Glassnode.com, chart from TradingView.com
Editorial Process for bitcoinist is centered on delivering thoroughly researched, accurate, and unbiased content. We uphold strict sourcing standards, and each page undergoes diligent review by our team of top technology experts and seasoned editors. This process ensures the integrity, relevance, and value of our content for our readers.
2025-09-26 08:555mo ago
2025-09-26 04:315mo ago
Prediction: Bitcoin Will Be Worth $0 or $500,000 in 10 Years
I'm about to make the most accurate Bitcoin (BTC -2.03%) prediction you'll ever read: In 2035, Bitcoin will either be worth practically nothing or it'll be worth half a million dollars. Maybe more.
2025-09-26 08:555mo ago
2025-09-26 04:325mo ago
925,865,148 XRP in 24 Hours Puts XRP Back Around 'Billionaire Club'
Disclaimer: The opinions expressed by our writers are their own and do not represent the views of U.Today. The financial and market information provided on U.Today is intended for informational purposes only. U.Today is not liable for any financial losses incurred while trading cryptocurrencies. Conduct your own research by contacting financial experts before making any investment decisions. We believe that all content is accurate as of the date of publication, but certain offers mentioned may no longer be available.
In the current market cycle, XRP has been displaying both positive and negative signals. Its most recent trading activity put nearly a billion XRP coins — 925,865,148 XRP in a 24-hour period — into circulation across wallets and exchanges. This significant shift in liquidity has brought XRP into the public eye and sparked speculation about whether the token is preparing for a new bull run or is bucking sell-side pressure.
XRP's market placementJust above the 200-day moving average and close to the 100-day EMA, XRP is presently trading at about $2.74 on the charts. Lower highs have been forming since August, and recent price action has been contained within a descending triangle pattern. The 200 EMA is still a powerful support level, but the break below the short-term trendline suggests waning bullish momentum. If this region is not held, XRP may see further declines, with $2.60 serving as one of the most important support levels.
XRP/USDT Chart by TradingViewThe nearly billion XRP that was exchanged in a single day demonstrates strong usage and liquidity, and on-chain data validates increased network activity. Either major accumulation phases or a redistribution of holdings across exchanges are suggested by large transactions, which are frequently associated with whales and institutional players. Large flows like these usually occur before volatility spikes, which either cause corrections when selling outpaces buying or push XRP higher with renewed demand.
HOT Stories
Exhaustion of bearsWith the Relative Strength Index (RSI) circling between 38 and 40, XRP is getting close to oversold territory without yet reaching extreme levels. If support levels hold, a technical bounce may be possible. Volume trends, however, are still inconsistent. Recent sessions have been dominated by spikes in sell pressure, suggesting that short-term market sentiment is slightly bearish.
Because of its steady transaction volume and usefulness for cross-border settlement, XRP is still relevant in the altcoin market on a larger scale. Even though XRP is still one of the most actively traded digital assets, traders should exercise caution until a clear break above the descending resistance trendline validates a renewed bullish structure, as evidenced by the nearly billion-dollar daily transfer.
Rebuilding momentum toward $3.20-$3.50 is possible if XRP stays above $2.74-$2.80. The Billionaire Club movement might be regarded as the precursor to a subsequent period of correction if not.
2025-09-26 08:555mo ago
2025-09-26 04:335mo ago
Curve Finance Founder Michael Egorov Launches Bitcoin Yield Protocol
Yield Basis aims to unlock sustainable Bitcoin yield on-chain, starting with capped liquidity pools. Sep 26, 2025, 8:33 a.m.
Michael Egorov, founder of Curve Finance, has launched Yield Basis, a decentralized protocol built to provide sustainable BTC$109,658.51 yield while eliminating impermanent loss (IL), one of decentralized finance’s longest-running challenges.
Bitcoin holders have long faced limited opportunities for on-chain returns. Lending markets rarely offer more than a fraction of a percent, while automated market maker (AMM) pools have exposed users to IL — the risk of losing value when token prices diverge. Even in favorable conditions, yields rarely topped 1–2%.
STORY CONTINUES BELOW
Yield Basis tackles this by reengineering the AMM model. The protocol removes IL risk altogether, which Egorov says will enable deeper Bitcoin liquidity on-chain and more attractive yield opportunities for institutional and professional investors. To manage early growth, three pools launched with a $1 million deposit cap each.
The system borrows from Curve’s five years of infrastructure resilience, adopting a vote-escrow mechanism (veYB) for governance. Token holders must lock their YB to participate in governance and earn protocol fees, distributed in either Curve’s crvUSD stablecoin or wrapped Bitcoin. Unlike many DeFi projects, token emissions aren’t simply handed to liquidity providers; they are tied to position yield, a model Egorov calls “value-protecting.”
Yield Basis secured $5 million in early 2025 funding and is the first project to debut on the joint Legion and Kraken launchpad, where the community can access its token sale. While Bitcoin is the initial focus, Egorov says the protocol’s impermanent loss solution could extend to Ethereum, tokenized commodities or even stocks — potentially broadening the scope of yield-bearing assets on-chain.
AI Disclaimer: Parts of this article were generated with the assistance from AI tools and reviewed by our editorial team to ensure accuracy and adherence to our standards. For more information, see CoinDesk's full AI Policy.
More For You
Stablecoin Market Could Reach $4 Trillion by 2030, Citi Says in Revised Forecast
14 hours ago
Bank tokens may ultimately surpass stablecoins in transaction volume, report said.
What to know:
Citi raises its 2030 stablecoin issuance forecast to a $1.9 trillion base case and a $4 trillion bull case.Stablecoins could support up to $200 trillion in transactions at scale.Bank tokens may overtake stablecoins as corporates seek regulatory safeguards.Read full story
2025-09-26 08:555mo ago
2025-09-26 04:355mo ago
Bitcoin Staking ETP Debuts on London Stock Exchange
DeFi Technologies, through its subsidiary Valour Digital Securities, has launched the world's first physically-backed Bitcoin Staking exchange traded product. The product is called 1Valour Bitcoin Physical Staking (1VBS).
2025-09-26 08:555mo ago
2025-09-26 04:365mo ago
BlackRock exec says crypto ETF institutional adoption still early, XRP and SOL ETFs unconfirmed
BlackRock's global head of digital assets, Robbie Mitchnick, believes the institutional adoption of crypto exchange-traded funds is still in its early stages. During a Sept.
2025-09-26 08:555mo ago
2025-09-26 04:375mo ago
Ethereum ETFs extend losses for fourth day as ETH slips to $3,900
Ethereum ETFs have suffered another day of outflows, dragging ETH below the key $4,000 mark as institutional sentiment turns bearish.
Summary
Ethereum ETFs posted outflows reaching $251 million on Sept 25, the largest single-day redemption this week, reflecting sharp institutional pullback.
Fidelity’s FETH fund accounted for over 60% of the day’s losses, with $158 million withdrawn.
ETH price has dropped to $3,900, currently testing support around $3,800.
Ethereum ETFs recorded net outflows of $251.20 million on Sept. 25, marking the fourth consecutive day of withdrawals. Per SoSoValue data, the bulk came from Fidelity’s FETH fund, which saw $158 million leave the market, underscoring the sustained bearish sentiment around Ethereum-focused institutional products.
Grayscale’s ETHE and Bitwise ETHW followed far behind with $30 million and $27 million, respectively, while VanEck ETHV posted the lowest figure of $1.4 million.
The latest withdrawals marked the largest single-day redemption this week and pushed the week’s total losses to more than $547 million, underscoring waning demand for Ethereum exposure among institutional investors.
By comparison, Bitcoin ETFs have fared better. While they also posted similar outflows in the latest session, their weekly performance has been significantly stronger than their ETH (ETH) counterparts.
Ethereum ETF outflows deepen price woes
The heavy withdrawals in the exchange-traded funds come as Ethereum continues to trade lower, now below the 4,000 mark. At press time, ETH sits at $3,939, down roughly 2.3% on the day and 13% over the past week.
The second-largest cryptocurrency has seen a consistent downtrend that has erased a large chunk of its recent gains, now close to the $3,800 support zone. On the technical side, indicators suggest weakened momentum and potential for a technical rebound if buyers step in.
If the decline persists and Ethereum fails to hold above $3,900, the next key support sits near $3,750–$3,800, while upside attempts will face resistance around $4,100.
Overall, market sentiment appears fragile, with ETH’s inability to stabilize suggesting caution in the short term. A reversal will likely require a clear bullish catalyst or macro shift.
2025-09-26 08:555mo ago
2025-09-26 04:415mo ago
Sui price tests support near $3.10 as traders eye recovery amid rising institutional demand
Sui price is testing support at $3.10 as rising trading volume and new partnerships hint at long-term strength.
Summary
SUI trades at $3.13, down 18% weekly, with $1.66B spot volume up 46% in 24h.
Futures volume rises 23% to $7.48B while open interest falls 4.4%, showing cautious positioning.
New deals with t’order, CUDIS Wellness, and Google AI highlight institutional and real-world adoption.
Sui is trading at $3.13 at press time, down 3.5% in the past 24 hours, as the token approaches key support levels. Over the past week, it has dropped 18%, while in the past 30 days, it is still down 10%.
Daily trading activity shows a surge in market interest, with $1.66 billion in spot volume recorded in the last 24 hours, a 45.9% jump compared to the previous day. On the derivatives side, CoinGlass data shows that Sui’s (SUI) open interest fell 4.4% to $1.69 billion, while futures volume rose 23% to $7.48 billion.
This combination implies that although traders are engaging more actively, many are closing out positions rather than opening new ones.
New partnerships drive long-term use cases
Despite the near-term pullback, Sui continues to expand its ecosystem with major partnerships that strengthen its institutional and real-world presence.
On Sept. 24, Sui announced a partnership with t’order, the leading table-ordering platform in South Korea, T’order processes $4.3 billion annually and serves 35 million users. Using Sui’s sub-0.5-second transaction speeds and Walrus storage for safe loyalty data, the partnership integrates a KRW-pegged stablecoin across 300,000 point-of-sale devices.
A day later, Sui partnered with CUDIS Wellness to bring AI-powered smart rings and health data management onchain. Through Walrus and SEAL, users will own and monetize encrypted biometric data, aligning Sui with the growing wellness sector.
Sui and Google AI also partnered to introduce the Agentic Payments Protocol earlier this month. This system opens up new use cases in DeFi, IoT, and enterprise automation by enabling AI agents to make payments on their own.
Sui price technical analysis
On the daily chart, SUI is trading close to the lower Bollinger band at $3.13, indicating oversold conditions. The relative strength index at 38 is near the oversold zone, while the Stochastic RSI and Williams %R both indicate possible buy conditions.
Sui daily chart. Credit: crypto.news
All of the major SMAs and EMAs, from the 10-day ($3.38) to the 200-day ($3.20), flash sell signals, a bearish sign. Momentum and MACD indicators also lean bearish, showing the trend is still weak.
In the short term, holding above $3.10 support is critical. The $2.90–$3.00 range might be the next target if there is a breakdown. On the upside, the first indication of a potential rebound would be the recovery of the 20-day SMA around $3.46.
2025-09-26 07:545mo ago
2025-09-26 02:545mo ago
Einhorn warns AI gold rush risks colossal capital wipeout
Artificial intelligence may change the world, but Wall Street veteran David Einhorn thinks the spending spree behind it could leave investors nursing huge losses.
Speaking at the New York Stock Exchange, the Greenlight Capital founder said the trillion-dollar push into AI infrastructure by the likes of Apple, Meta and OpenAI has reached “extreme” levels.
While he expects the technology to exceed today’s lofty forecasts in the long run, he doubts that annual outlays of $500 billion to $1 trillion can generate strong returns for shareholders.
“The numbers that are being thrown around are so extreme that it’s really, really hard to understand them,” Einhorn said druing a panel discussion.
“I’m sure it’s not zero, but there’s a reasonable chance that a tremendous amount of capital destruction is going to come through this cycle.”
Sam Altman of OpenAI has spoken of spending “trillions,” while Mark Zuckerberg has floated hundreds of billions for data centres. Apple has pledged $500 billion in domestic investment over four years.
Einhorn also struck a downbeat note on the broader economy, citing weak job creation, shrinking workweeks and poor productivity as signs the US may already be in recession.
2025-09-26 07:545mo ago
2025-09-26 02:565mo ago
Norwegian Group Places New Order for Boeing 737 MAX
, /PRNewswire/ -- Boeing [NYSE: BA] and Norwegian Group announced today that the airline group has placed an order for 30 737-8 airplanes as the airline looks to expand its service across Europe.
The agreement represents the group's first direct Boeing order since 2017 and increases their 737 MAX order book to 80 airplanes.
"This milestone aircraft order is on attractive terms and secures our fleet growth in a way that supports our planned growth and sustainability targets. By exercising the options and adjusting the delivery profile, we maintain flexibility while reinforcing our commitment to operating one of the most modern and fuel-efficient fleets in Europe," said Geir Karlsen, CEO of Norwegian. "These aircraft will not only lower emissions but also provide our customers with an even better travel experience. We are pleased to extend our solid long-term partnership with Boeing through this order."
Norwegian has predominantly operated Boeing single-aisle airplanes since placing its first order for the Next-Generation 737-800 in 2007. It was the first European airline to take delivery of the 737 MAX in 2017 and was also the first airline to operate the 737-8 model on transatlantic routes between Europe and the U.S.
In 2022, Norwegian restructured its order book, firming its commitment to 50 737-8s with options for an additional 30 airplanes.
"Norwegian's impressive performance over the past few years has demonstrated the strength of their network, business model and strategy. Today's agreement for an additional 30 737-8s will support their ambition to be the airline of choice in Scandinavia, providing flexibility to expand across Europe and beyond," said Brad McMullen, Boeing senior vice president of Commercial Sales and Marketing. "Norwegian has been a great partner to the 737 program, having placed over 200 orders for the 737 NG and MAX since 2007. We are honored that Norwegian continues to place its trust in our 737 team to grow its business."
The 737-8 model can carry up to 200 passengers depending on configuration, with a range of up to 3,500 nautical miles (6,480 km). The 737 MAX family is well-suited to support airline fleet modernization by reducing fuel use and carbon emissions by 20% compared to the airplanes they replace.
About Norwegian
The Norwegian group is a leading Nordic aviation company, headquartered at Fornebu outside Oslo, Norway. The company has over 8,200 employees and owns two of the prominent airlines in the Nordics: Norwegian Air Shuttle and Widerøe's Flyveselskap. Widerøe was acquired by Norwegian in 2024, aiming to facilitate seamless air travel across the two airline's networks.
Norwegian Air Shuttle, the largest Norwegian airline with around 4,700 employees, operates an extensive route network connecting Nordic countries to key European destinations. In 2024, Norwegian carried 22,6 million passengers and maintained a fleet of 86 Boeing 737-800 and 737 MAX 8 aircraft.
About Boeing
As a leading global aerospace company, Boeing develops, manufactures and services commercial airplanes, defense products and space systems for customers in more than 150 countries. As a top U.S. exporter, the company leverages the talents of a global supplier base to advance economic opportunity, sustainability and community impact. Boeing's diverse team is committed to innovating for the future and living the company's core values of safety, quality and integrity. Learn more at www.boeing.com.
Contact:
Boeing Media Relations
[email protected]
SOURCE Boeing
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
2025-09-26 07:545mo ago
2025-09-26 03:055mo ago
Is Rivian Stock Your Ticket to Becoming a Millionaire?
Rivian looks increasingly like it will be a successful EV start-up, but don't get overexcited by the Tesla similarities.
After Tesla (TSLA -4.29%) proved that a start-up electric car company could take on the traditional automakers, Wall Street jumped into action. That was when Rivian (RIVN -0.44%) came public, to much fanfare. Fast forward a few years to the current day, and Rivian's stock price has fallen some 90% from its all-time highs. Is this a diamond in the rough that could turn you into a millionaire in a Tesla-style success story, or should you have more modest expectations?
Rivian has done big things
To give credit where credit is due, Rivian has achieved a huge amount of success in a very short period of time. It basically went from an idea -- making electric vehicles (EVs) -- to an operating business with a well-respected EV truck and an EV delivery van used widely by retail powerhouse Amazon (AMZN -0.84%). That isn't something that could have been achieved if Rivian didn't have its act together.
Image source: Rivian.
Notably, in late 2024, Rivian hit a key milestone, achieving a modest gross profit for the first time. While a gross profit only means that it was able to generate more revenue from selling its vehicles than it cost to produce them, that is a key step toward positive earnings.
The modest gross profit came after Rivian hit another important goal, scaled production. It delivered more than 10,000 vehicles in the second quarter of 2025, which is a substantial number. It also has a new truck called the R2 coming out next year, which will be geared to the mass market. That should help to further increase volume, which will allow Rivian to spread its costs over even more vehicles.
In many ways, Rivian is following in Tesla's footsteps. Given the massive stock price advance Tesla has made over its history, some investors might see Rivian as a second chance to catch a little of the Tesla opportunity they might have missed. Don't get overly excited.
Rivian has a long way to go
With a well-respected product and key partners like tech giant Amazon and automaker Volkswagen (which has agreed to provide fresh capital to Rivian based on Rivian's ability to meet certain business goals), Rivian seems like it will establish itself as a sustainably profitable business. However, this goal is still likely to be at least a few years away, given the need to invest in the business and research and development right now. Rivian could help you reach a seven-figure net worth, but it isn't likely to do so quickly.
Moreover, the competition set today is much larger than it was when Tesla entered the auto market. At the time, Tesla was basically the only company making EVs. Today, there are a number of sizable EV makers. Virtually all of the traditional automakers are in the space, too. Even if Rivian is successful, it could still just produce a modest profit at the bottom of its income statement, thanks to the changed competitive landscape.
That said, even that outcome would require strong execution. Although Rivian has lived up to its goals, for the most part, so far, there's no guarantee that it will continue to do so in the future. If the company starts missing its targets, investors are likely to turn deeply negative on the stock.
How much more negative could they get after a 90% price decline? Well, the stock happens to be up nearly 23% over the past year, which is notably better than the nearly 17% gain of the S&P 500 index (^GSPC -0.50%). Even after a 90%+ decline, there's still ample room for a deep drawdown, as investors appear to have priced in a lot of good news in recent days.
Risk takers may find it attractive
It probably wouldn't be a great idea to bet your house on Rivian. But it has achieved a great deal in a short period of time, with material opportunity for more success in the future. The problem is that it could also fall short of its goals and flame out, like many upstart EV makers have already done. If you see the execution strength and want to add Rivian to a diversified portfolio, it could help you reach millionaire status. Just go in recognizing the risk, which is material, and the time period you need to consider, which is long.
That's why more conservative investors will probably want to sit on the sidelines for now. It makes a great deal of sense to wait at least until the R2 has been brought to market, so investors can assess how well the new car does with consumers.
Reuben Gregg Brewer has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Amazon and Tesla. The Motley Fool recommends Volkswagen Ag. The Motley Fool has a disclosure policy.
2025-09-26 07:545mo ago
2025-09-26 03:065mo ago
Warren Buffett Is Retiring in 3 Months, and His $177 Billion Warning to Wall Street Rings Louder Than Ever
The Oracle of Omaha's actions speak louder than his words.
For 60 years, Berkshire Hathaway (BRK.A -0.04%) (BRK.B -0.27%) CEO Warren Buffett has been dazzling Wall Street and investors with his ability to spot amazing deals hiding in plain sight. Since taking the reins, he's overseen a nearly 6,000,000% cumulative gain in his company's Class A shares (BRK.A).
But this glorious investment career is in its twilight. During Berkshire's annual shareholder meeting in early May, Buffett announced his intent to retire from the CEO role at the end of this year and hand the baton over to predetermined successor Greg Abel. Abel has vowed to maintain the same ethos that Buffett and late right-hand-man Charlie Munger promoted, which includes a long-term vision and an unwavering focus on value.
Berkshire Hathaway CEO Warren Buffett. Image source: The Motley Fool.
However, the Oracle of Omaha isn't going quietly into retirement (as CEO). Though he's an unabashed optimist who would never bet against America, his actions over the last three years speak louder than his words and give life to his $177 billion warning to Wall Street.
The Oracle of Omaha has been a big-time seller of stocks
Historically, Berkshire Hathaway's success has derived from Warren Buffett's willingness to make acquisitions and purchase stakes in amazing businesses. This is why investors wait on the edge of their seats for the quarterly release of Berkshire's Form 13F, which divulges precisely which stocks its billionaire boss has been buying and selling.
Despite being a long-term optimist, Buffett has been a decisive net seller of stocks for 11 consecutive quarters:
On an aggregate basis, Berkshire's billionaire boss has sold $177.4 billion more in stock than he's purchased from Oct. 1, 2022 through June 30, 2025.
It's worth noting that Buffett has also gone cold turkey on his favorite stock to buy. From mid-July 2018 through the midpoint of 2024, Buffett used nearly $78 billion to repurchase shares of Berkshire Hathaway stock. But following this 24-consective-quarter stretch of buying back shares, Buffett has now gone 13 straight months (June 1, 2024 – June 30, 2025) without spending a dime on repurchases.
There's only one explanation for Warren Buffett's silent but pertinent warning: stock valuations are worrisome.
The stock market is historically pricey, and Buffett knows it
Valuing stocks or the broader market can be tricky, because there's no one-size-fits-all blueprint or line in the sand when it comes to what's cheap and what's overpriced. The variations of opinion we see from investors, with regard to valuation, is what makes the stock market a market!
But certain valuation markers leave little room for interpretation.
For example, the S&P 500's (^GSPC -0.50%) Shiller price-to-earnings (P/E) Ratio is pushing to rarified territory. You'll occasionally find the Shiller P/E referred to as the cyclically adjusted P/E Ratio, or CAPE Ratio.
Whereas the traditional P/E ratio takes into account trailing-12-month earnings, which makes it susceptible to being tripped up by recessions, the Shiller P/E is based on average inflation-adjusted earnings over the last 10 years. It's an ideal valuation measure when looking back multiple decades or more than a century.
S&P 500 Shiller CAPE Ratio data by YCharts.
As of the closing bell on Sept. 19, the Shiller P/E clocked in at 39.95, which not only marks the highest multiple during the current bull market, but the third-priciest reading during any continuous bull market dating back 154 years. One more reasonable up day for the benchmark S&P 500 would more than likely make this the second-priciest market in history.
The only two times the S&P 500's Shiller P/E has maintained a higher reading was during the first week of January 2022, where it topped 40 by a few hundredths, and when it peaked at a multiple of 44.19 in December 1999.
The prior top in January 2022 was followed by a 25% peak-to-trough drop for the S&P 500, and an even steeper decline for the growth-focused Nasdaq Composite (^IXIC -0.50%). Meanwhile, the round-trip from top to bottom with the dot-com bubble from 2000 through 2002 was 49% for the S&P 500 and a whopping 78% for the Nasdaq Composite.
While former steep declines in Wall Street's major stock indexes don't guarantee what's to come, prior occurrences of the S&P 500's Shiller P/E nearing/topping 40 were eventually met with significant downside.
Warren Buffett being a net seller of $177 billion in stock is his way of warning investors that he expects meaningful downside in equities.
Image source: Getty Images.
Warren Buffett's legacy will be a historically large treasure chest for Greg Abel to deploy
One thing the Shiller P/E is not is a timing tool. Although it's had a knack for foreshadowing eventual trouble for Wall Street's major stock indexes, it's not helpful in deciphering when inflection points will be reached. As previously pricey market's have shown, a popular trend or game-changing innovation can fan the flames of investor exuberance for years, as occurred prior to the dot-com bubble bursting.
But at some point in the presumed not-too-distant future, a stock market correction (potentially a sizable one) will rear its head and send the S&P 500 and Nasdaq Composite notably lower. When this happens, Buffett's journey as Berkshire Hathaway's CEO will be complete, as he'll have left his successor, Greg Abel, with a near-record amount of capital to deploy -- $344.1 billion, including U.S. Treasuries, as of June 30.
The Oracle of Omaha has made a living being exceptionally patient and pouncing on price dislocations when they arise.
One of his most-famous (and profitable) investment dealings is infusing Bank of America (BAC 0.26%) with $5 billion in cash shortly after the financial crisis. In exchange for shoring up BofA's balance sheet, Berkshire Hathaway received $5 billion in Bank of America preferred stock yielding 6% annually.
While collecting a $300 million annual dividend was fun, the real payoff was the 700 million common stock warrants of BofA Berkshire received in August 2011 and exercised in mid-2017 at just $7.14 per share. It provided an instant $12 billion windfall for Berkshire Hathaway, which has since grown.
It's tough to tell what the next "Bank of America" moment is going to be for Berkshire Hathaway in a post-Buffett era. What can be said is that if Abel and his top advisors stick to this disciplined strategy that made Berkshire a phenomenal investment for decades, it'll be set up to outperform once the next market downturns arrives.
Bank of America is an advertising partner of Motley Fool Money. Sean Williams has positions in Bank of America. The Motley Fool has positions in and recommends Berkshire Hathaway. The Motley Fool has a disclosure policy.
2025-09-26 07:545mo ago
2025-09-26 03:145mo ago
The Best Warren Buffett Stocks to Buy With $300 Right Now
You don't need to be a billionaire to invest like Buffett.
Legendary investor Warren Buffett is in the final year of leading his mighty conglomerate, Berkshire Hathaway (BRK.A -0.04%) (BRK.B -0.27%). The Oracle of Omaha, now 95, plans to retire at the end of the year following a 60-year run that turned a downtrodden textile company into a hugely successful company valued at more than $1 trillion.
Buffett's investing principles are comparatively simple, but not many have been able to duplicate them. He believes in buying stock in companies with outstanding management, a great position in their industry, solid revenue and earnings, and often, a generous dividend. By buying dividend stocks in companies that pay investors to hold them, Buffett and Berkshire Hathaway have been able to build wealth even faster.
Berkshire Hathaway has long-term investments in dozens of companies, but three stand out right now as ideal companies for anyone wanting to start a buy-and-hold portfolio. And you don't have to be a billionaire to invest like Buffett -- you need less than $300 total to get a share of Bank of America (BAC 0.26%), Chevron (CVX 0.97%), and Kroger (KR -0.06%).
Image source: The Motley Fool.
Bank of America: Buffett's favorite bank stock
Buffett and Berkshire Hathaway have positions in several financial companies. Berkshire owns insurance companies Geico, General Re, and Berkshire Hathaway; stock in credit card companies American Express, Visa, and Mastercard; a stake in the the credit ratings and analytics company Moody's; and a small percentage of Jefferies Financial Group, the investment bank.
But Bank of America is by far the company's biggest bank stock, as Berkshire holds 605.2 million shares for a $31.3 billion stake. Bank of America makes up 10% of Berkshire's entire portfolio. The North Carolina–based financial institution has about 69 million customers and maintains 3,700 locations across the country, as well as a network of 15,000 ATMs and a robust digital presence.
The company has benefited from a period of elevated interest rates that brought in increased net interest income -- the company reported $14.7 billion in net interest income in the second quarter, up 7% from a year ago. And while the Federal Reserve is now starting to lower rates, Bank of America will still be just fine as people begin to take out new loans or refinance mortgages.
Bank of America is also attractive for its 15.2 price-to-earnings ratio and its 2.1% dividend yield.
Chevron: The energy powerhouse
Buffett and Berkshire Hathaway recognize the importance of energy and fossil fuels in today's economy, and the conglomerate has sizable investments in ExxonMobil, Chevron, and Occidental Petroleum.
I like Chevron here. Even though oil prices have been down this year, Chevron still generates a massive amount of free cash flow -- $4.9 billion in the second quarter, up from $2.3 billion a year ago.
The company recently completed its $55 billion acquisition of Hess, emerging victorious over ExxonMobil in a legal battle that saw it win access to the Guyana Stabroek Block that is purportedly the biggest oil discovery in decades with more than 11 billion barrels of oil.
Chevron already recorded record production in the second quarter for the Permian Basin, with 1 billion barrels of oil per day, and I expect production to increase following the Hess merger.
The company pays a generous dividend yield of 4.4%.
Kroger: The defensive pick
Even when spending tightens up and consumer confidence falls, people still need to eat. While consumer discretionary stocks can come under pressure, consumer staples stocks, such as grocery stores, often can be a safer place for investors to put their money. That's where Kroger comes in.
Kroger is the second-largest grocery store chain in the U.S., behind only Walmart. The company has more than 2,700 locations, 2,250 pharmacies, and 1,700 fuel locations scattered throughout 35 U.S. states and the District of Columbia.
The Cincinnati-based grocer reported $33.9 billion in sales in the second quarter, including fuel and specialty pharmacy sales. But without those items, sales were up 3.8% from last year, indicating that people are spending more money in Kroger's grocery stores.
Part of that comes from Kroger's increased emphasis on growing its own in-house brands of food products, which the company can offer at a lower price point and a greater profit than national brands.
Kroger still has a cheap valuation with a P/E ratio of 16.4, which is lower than that of Walmart (38.7), Costco Wholesale (53.5), or Sprouts Farmers Market (26.7). Coupled with a dividend yield of 2.1%, Kroger offers a compelling investment opportunity.
American Express is an advertising partner of Motley Fool Money. Bank of America is an advertising partner of Motley Fool Money. Patrick Sanders has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Berkshire Hathaway, Chevron, Costco Wholesale, Jefferies Financial Group, Mastercard, Moody's, Visa, and Walmart. The Motley Fool recommends Kroger, Occidental Petroleum, and Sprouts Farmers Market. The Motley Fool has a disclosure policy.
Nvidia has dominated the AI chip market since the AI boom started.
Nvidia (NVDA 0.35%) has built an artificial intelligence (AI) dynasty over the past few years. In its earlier days, it was known as a chip designer focused on the video gaming market, but the company shifted into the high-growth AI opportunity early in the story -- and this resulted in explosive growth. Today, Nvidia sells its famous graphics processing units (GPUs) along with a wide range of products and services to power AI, and all of this has resulted in billion-dollar earnings -- and a more than $4 trillion market value for the company.
Nvidia looks positioned for long-term success in the AI market, but it's important to remember that it's not alone here. Other players have carved out a spot with offerings spanning the AI theme -- from chips to servers and capacity for running AI workloads. And one particular player has grown its presence in an area that could make it a Nvidia rival: the chip market. In fact, this company recently reported significant gains in revenue and a major customer win. Could this AI chipmaker surpass Nvidia by 2030? Let's find out.
Image source: Getty Images.
Soaring market value
This company, like Nvidia, has seen its market value soar in recent times -- in fact, it joined the "trillion dollar club" this year when its market capitalization reached $1 trillion for the first time ever. (The trillion dollar club isn't a real club, but instead a way of referring to companies that are valued $1 trillion or more.)
So, which company am I referring to? Broadcom (AVGO -0.94%), a networking specialist that plays an integral part in powering everything from smartphones to data centers. The company makes thousands of products used across many environments and also sells enterprise software solutions -- in fact, Broadcom serves most of the Fortune 500 companies with its software. All of this has helped Broadcom increase earnings into the billions of dollars over time.
AVGO Revenue (Annual) data by YCharts
But what's truly been driving Broadcom's revenue in recent times has been its work in the AI market. Broadcom's top networking solutions -- such as Tomahawk switches and Jericho routers -- along with the company's AI chips, known as XPUs, have been gaining ground with big cloud service providers as they scale up their AI infrastructure.
Nvidia vs Broadcom
How do Nvidia's and Broadcom's AI chips compare? Nvidia's GPUs are the most powerful on the market and are general purpose, meaning they can supercharge any AI task. Broadcom designs XPUs to serve specific functions for customers, making them custom solutions. This clearly appeals to AI customers because Broadcom said the XPU business made up 65% of its AI revenue in the recent quarter and orders from three major customers continue to grow.
On top of this, Broadcom said it won a $10 billion order for AI racks based on its XPUs. The company didn't identify this new customer, but analysts have suggested it may be AI research lab OpenAI.
So, the advantage Broadcom offers customers is the ability to choose XPUs specific to particular tasks -- and these custom solutions may be cheaper than going exclusively for Nvidia's top GPUs.
Now, let's get back to our question: Could Broadcom surpass Nvidia by 2030? That's the year AI infrastructure spending may reach $4 trillion, according to Nvidia chief Jensen Huang. I think that Broadcom could see explosive growth by that time and clearly become a major AI player -- this should boost its stock performance and lead to gains in market value too.
Nvidia's expertise
But, even though Broadcom likely will carve out a leading market position, it's unlikely to unseat Nvidia. This is because Nvidia's general purpose expertise offers it a vast audience -- the company's GPUs and related products and services provide top performance and are able to supercharge any AI task, making them very versatile. That will appeal to many customers over time.
In fact, Nvidia's and Broadcom's chip offerings actually are complementary, and many customers may opt to integrate both in their data centers. The AI opportunity is an enormous one, and this is great news for these companies and investors because it indicates there will be many winners. Broadcom and Nvidia already have demonstrated this as they've reported skyrocketing earnings in recent years.
All of this means that even though Broadcom is unlikely to surpass Nvidia by 2030, the stock still makes a fantastic AI investment.
Adria Cimino has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Nvidia. The Motley Fool recommends Broadcom. The Motley Fool has a disclosure policy.
September 26, 2025 3:15 AM EDT | Source: Questcorp Mining Inc.
Vancouver, British Columbia--(Newsfile Corp. - September 26, 2025) - Questcorp Mining Inc. (CSE: QQQ) (OTCQB: QQCMF) (FSE: D910) (the "Company" or "Questcorp") is pleased to announce that it will offer (the "Offering") up to 17,500,000 units (each, a "Unit") by way of non-brokered private placement at a price of $0.20 per Unit for gross proceeds of up to $3,500,000. Each Unit will consist of one common share of the Company (each, a "Share") and one-half-of-one share purchase warrant (each whole warrant, a "Warrant"). Each Warrant will entitle the holder to acquire an additional common share of the Company at a price of $0.30 for a period of twenty-four months following closing of the Offering, subject to accelerated expiry in the event the closing price of the Shares is $0.50 or higher for ten consecutive trading days.
The Company expects to utilize the proceeds of the Offering for advancement of ongoing exploration and drill work at the La Union Gold and Silver Project, upcoming exploration work at its North Island Copper Property and for general working capital purposes.
In connection with completion of the Offering, the Company will pay finders' fees to eligible third-parties who have introduced subscribers to the Offering. All securities issued in connection with the Offering will be subject to restrictions on resale for a period of four-months-and-one-day in accordance with applicable securities laws. Completion of the Offering remains subject to receipt of regulatory approvals.
About Questcorp Mining Inc.
Questcorp Mining Inc. is engaged in the business of the acquisition and exploration of mineral properties in North America, with the objective of locating and developing economic precious and base metals properties of merit. The Company holds an option to acquire an undivided 100% interest in and to mineral claims totaling 1,168.09 hectares comprising the North Island Copper Property, on Vancouver Island, British Columbia, subject to a royalty obligation. The Company also holds an option to acquire an undivided 100% interest in and to mineral claims totaling 2,520.2 hectares comprising the La Union Project located in Sonora, Mexico, subject to a royalty obligation.
This news release includes certain "forward-looking statements" under applicable Canadian securities legislation. Forward-looking statements include, but are not limited to, statements with respect to the intended use of proceeds from the Offering. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include but are not limited to: the ability of Riverside to secure geophysical contractors to undertake orientation surveys and follow up detailed survey to confirm and enhance the drill targets as contemplated or at all, general business, economic, competitive, political and social uncertainties, uncertain capital markets; and delay or failure to receive board or regulatory approvals. There can be no assurance that the geophysical surveys will be completed as contemplated or at all and that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/268095
2025-09-26 07:545mo ago
2025-09-26 03:185mo ago
The Stock Market Is Historically Pricey: Here's 1 Reason Realty Income Is Still a No-Brainer Buy
The S&P 500 currently trades at nearly 23 times forward earnings. That is a historically high level, as the market has traded at an average of around 15 times forward earnings over the past couple of decades.
While the market is currently pricey, that's not the case with Realty Income (O -0.32%). The real estate investment trust (REIT) trades at a much lower level compared to the market and its peer group. That makes it a no-brainer buy in today's market.
Image source: Getty Images.
A dirt cheap REIT
Realty Income currently expects to generate between $4.24 and $4.28 per share of adjusted funds from operations (FFO) this year. With its share price currently around $60, the REIT trades at about 14 times its forward earnings. That's well below the S&P 500's valuation and that of other REITs in that broad market index, which currently trade at about 18 times forward earnings on average.
That low valuation is why Realty Income currently offers such a high dividend yield. At nearly 5.5% it's well above the S&P 500 (1.2%) and REIT sector average of around 4%.
Realty Income trades at a lower valuation compared to its peer group, despite delivering peer-leading total operational returns (dividend yield plus FFO growth rate) over the past several years. For example, it has delivered a 9.7% average annual total operational return over the past five years, well above the 7.7% average of other REITs in the S&P 500.
The company remains in a strong position to continue producing above-average returns. It has one of the best balance sheets in the sector, giving it ample financial capacity to continue expanding its portfolio. That should enable Realty Income to continue increasing its high-yielding dividend. The REIT has currently raised its payment for 112 straight quarters.
Realty Income's low valuation, especially for such a high-quality company, makes it a no-brainer buy in the currently richly valued investment environment.
Matt DiLallo has positions in Realty Income. The Motley Fool has positions in and recommends Realty Income. The Motley Fool has a disclosure policy.
2025-09-26 07:545mo ago
2025-09-26 03:185mo ago
BMW to recall over 196,000 US vehicles due to engine starter defect
A logo of BMW is seen inside a car dealer in Nijmegen, Netherlands February 26, 2025. REUTERS/Piroschka van de Wouw/File Photo Purchase Licensing Rights, opens new tab
CompaniesSept 26 (Reuters) - BMW
(BMWG.DE), opens new tab is recalling over 196,000 vehicles in the U.S. as the engine starter relay may corrode, leading to overheating and short circuit, increasing the risk of a fire, the U.S. National Highway Traffic Safety Administration said on Friday.
The issue affects multiple models including Toyota Supra and 2022 BMW 230i vehicles, the U.S. auto safety regulator said.
Sign up here.
BMW dealers will replace the engine starter, free of charge, NHTSA said in the notice.
Reporting by Ruchika Khanna in Bengaluru; Editing by Mrigank Dhaniwala
Our Standards: The Thomson Reuters Trust Principles., opens new tab
2025-09-26 07:545mo ago
2025-09-26 03:255mo ago
Global Dividend Growth Accelerates As The Bull Market Turns 3
SummaryCompany payouts are stronger compared to previous years, despite brewing macro risks.A weaker dollar and resilient consumer spending support record earnings and stock prices, even amid cautious CEO sentiment.We spot key events as the calendar flips to October, along with happenings at the biggest U.S. bank. Thapana Onphalai/iStock via Getty Images
Dividend-increase announcements are on the rise. According to the Wall Street Horizon research team, 71.9% of all dividend changes have been positive so far in 2025. That tops the comparable year-to-date figures of 68.8% and 68.6% from 2024 and 2023, respectively. In
Recommended For You
2025-09-26 07:545mo ago
2025-09-26 03:295mo ago
Natural Gas and Oil Forecast: WTI Holds $65 While Gas Faces Key $3.30 Resistance
Important DisclaimersThe content provided on the website includes general news and publications, our personal analysis and opinions, and contents provided by third parties, which are intended for educational and research purposes only. It does not constitute, and should not be read as, any recommendation or advice to take any action whatsoever, including to make any investment or buy any product. When making any financial decision, you should perform your own due diligence checks, apply your own discretion and consult your competent advisors. The content of the website is not personally directed to you, and we does not take into account your financial situation or needs.The information contained in this website is not necessarily provided in real-time nor is it necessarily accurate. Prices provided herein may be provided by market makers and not by exchanges.Any trading or other financial decision you make shall be at your full responsibility, and you must not rely on any information provided through the website. FX Empire does not provide any warranty regarding any of the information contained in the website, and shall bear no responsibility for any trading losses you might incur as a result of using any information contained in the website.The website may include advertisements and other promotional contents, and FX Empire may receive compensation from third parties in connection with the content. FX Empire does not endorse any third party or recommends using any third party's services, and does not assume responsibility for your use of any such third party's website or services.FX Empire and its employees, officers, subsidiaries and associates, are not liable nor shall they be held liable for any loss or damage resulting from your use of the website or reliance on the information provided on this website.Risk DisclaimersThis website includes information about cryptocurrencies, contracts for difference (CFDs) and other financial instruments, and about brokers, exchanges and other entities trading in such instruments. Both cryptocurrencies and CFDs are complex instruments and come with a high risk of losing money. You should carefully consider whether you understand how these instruments work and whether you can afford to take the high risk of losing your money.FX Empire encourages you to perform your own research before making any investment decision, and to avoid investing in any financial instrument which you do not fully understand how it works and what are the risks involved.
2025-09-26 07:545mo ago
2025-09-26 03:445mo ago
Delta Air Lines Is Set To Soar Into A Second Century Of Flight
Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
2025-09-26 06:545mo ago
2025-09-26 01:005mo ago
Addex Therapeutics to Report 2025 Half-year and Second Quarter Financial Results on September 30, 2025 and Host Conference Call on October 1, 2025
Geneva, Switzerland, September 26, 2025 - Addex Therapeutics (SIX/NASDAQ: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological disorders, today announced that it will report its Half-Year and Second Quarter 2025 Financial Results on September 30, 2025 and host a conference call to discuss the results on October 1, 2025. Tim Dyer, CEO and Mikhail Kalinichev, Head of Translational Science, will provide a business update and review of the Addex product pipeline during a teleconference and webcast for investors, analysts and media at 16:00 CEST (15:00 BST / 10:00 EDT / 07:00 PDT) on October 1, 2025.
Title: Addex Therapeutics Reports Half-Year 2025 Financial Results and Provides Corporate Update
Date: October 1, 2025
Time: 16:00 CEST (15:00 BST / 10:00 EDT / 07:00 PDT)
Joining the Conference Call:
Participants are required to register in advance of the conference using the link provided below. Upon registering, each participant will be provided with Participant Dial-in numbers, and a unique Personal PIN.In the 10 minutes prior to the call’s start time, participants will need to use the conference access information provided in the e-mail received at the point of registering. Participants may also use the call me feature instead of dialing the nearest dial in number.
Webcast registration URL:
Addex is a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological disorders. Addex’s lead drug candidate, dipraglurant (mGlu5 negative allosteric modulator or NAM), is under evaluation for future development in brain injury recovery, including post-stroke and traumatic brain injury recovery. Addex’s partner, Indivior, has selected a GABAB PAM drug candidate for development in substance use disorders and has successfully completed IND enabling studies. Addex is advancing an independent GABAB PAM program for chronic cough. Addex also holds a 20% equity interest in a private spin out company, Neurosterix LLC, which is advancing a portfolio of allosteric modulator programs, including M4 PAM for schizophrenia, mGlu7 NAM for mood disorders and mGlu2 NAM for mild neurocognitive disorders. Addex shares are listed on the SIX Swiss Exchange and American Depositary Shares representing its shares are listed on the NASDAQ Capital Market, and trade under the ticker symbol “ADXN” on each exchange. For more information, visit www.addextherapeutics.com
Contacts:
Addex Forward Looking Statements:
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, including statements about the intended use of proceeds of the offering. The words “may,” “will,” “could,” “would,” “should,” “expect,” “plan,” “anticipate,” “intend,” “believe,” “estimate,” “predict,” “project,” “potential,” “continue,” “target” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Any forward-looking statements in this press release, are based on management's current expectations and beliefs and are subject to a number of risks, uncertainties and important factors that may cause actual events or results to differ materially from those expressed or implied by any forward-looking statements contained in this press release, including, without limitation, uncertainties related to market conditions. These and other risks and uncertainties are described in greater detail in the section entitled “Risk Factors” in Addex Therapeutics’ Annual Report on Form 20-F, prospectus and other filings that Addex Therapeutics may make with the SEC in the future. Any forward-looking statements contained in this press release represent Addex Therapeutics’ views only as of the date hereof and should not be relied upon as representing its views as of any subsequent date. Addex Therapeutics explicitly disclaims any obligation to update any forward-looking statements.
2025-09-26 06:545mo ago
2025-09-26 01:145mo ago
Prosus' OLX to buy French classified platform La Centrale in $1.3 billion deal
Prosus' logo is pictured on a smartphone in this illustration taken, December 4, 2021. REUTERS/Dado Ruvic/Illustration/File Photo Purchase Licensing Rights, opens new tab
Sept 26 (Reuters) - Online marketplace OLX will buy French motors classified platform La Centrale for 1.1 billion euros ($1.3 billion), its owner Prosus
(PRX.AS), opens new tab said on Friday.
Amsterdam-headquartered Prosus, which is majority-owned by South Africa's Naspers
(NPNJn.J), opens new tab and focused on food and lifestyle-ecommerce, reported in August a 54% jump in its ecommerce adjusted core earnings.
Sign up here.
On Friday it said that buying La Centrale would help it enter the European autos market and strengthen its ecommerce presence in the continent complementing the planned acquisition of meal delivery company Just Eat Takeaway
(TKWY.AS), opens new tab.
"I expect to invest more in AI technology in France," Prosus CEO Fabricio Bloisi said in a statement.
Prosus expects the deal to close by year-end.
($1 = 0.8563 euros)
Reporting by Alessandro Parodi; Editing by Jacqueline Wong and Matt Scuffham
Our Standards: The Thomson Reuters Trust Principles., opens new tab
2025-09-26 06:545mo ago
2025-09-26 01:155mo ago
Novartis to showcase transformative data in advanced prostate and early breast cancer at ESMO 2025
Key data from PSMAddition has been selected for a Presidential session; data to showcase the efficacy and safety of PluvictoTM plus standard of care (SoC) versus SoC alone in PSMA+ mHSPCNATALEE five-year analysis of Kisqali® to provide further long-term insights into risk of recurrence reduction in a broad EBC patient population New data for Pluvicto in prostate cancer and Kisqali in breast cancer strengthen the profiles of both medicines, with promise for new SoC in earlier disease settings Basel, September 26, 2025 – Novartis will present new data from 34 abstracts across its oncology portfolio at the European Society for Medical Oncology (ESMO) Congress 2025 in Berlin (October 17-21, 2025).
“We look forward to sharing new clinical data that underscores how we are reimagining treatment for breast and prostate cancer, advancing highly effective therapies designed to improve quality of life, enable more personalized care and ultimately provide more time for cancer patients,” said Dushen Chetty, PhD, Global Head of Oncology Development, Novartis, Ad Interim. “Our ambition is to set new standards of care in some of the most prevalent cancers by pioneering novel technologies like radioligand therapy.”
Key highlights of data accepted by ESMO include:
MedicineAbstract titleAbstract Number/
Presentation Details Pluvicto™ (lutetium (177Lu) vipivotide tetraxetan)Phase 3 trial of [177Lu]Lu-PSMA-617 combined with ADT + ARPI in patients with PSMA-positive metastatic hormone-sensitive prostate cancer (PSMAddition)#LBA6
Presidential Symposium 2 (Proffered Paper session)
October 19, 2025
16:30 – 18:15 CESTPluvicto™ (lutetium (177Lu) vipivotide tetraxetan)Associations between quantitative baseline 68Ga-PSMA-11 PET parameters and 177Lu-PSMA-617 efficacy in the PSMAfore Study#2390P
Poster Presentation
October 18, 2025
09:00 – 17:00 CESTPluvicto™ (lutetium (177Lu) vipivotide tetraxetan)Final analysis of patients treated with [177Lu]Lu-PSMA-617 in early access program in metastatic castration-resistant prostate cancer (mCRPC) in France#2389P
Poster Presentation
October 18, 2025
09:00 – 17:00 CEST[225Ac]-PSMA-617PSMAcTION trial-in-progress: a phase 2/3 randomized trial of [225Ac]Ac-PSMA-617 (225Ac-PSMA-617) versus standard of care in patients with PSMA-positive metastatic castration-resistant prostate cancer who progressed on or after [177Lu]Lu-PSMA therapy#2516TiP
Poster Presentation
October 18, 2025
09:00 – 17:00 CESTKisqali® (ribociclib)Adjuvant ribociclib (RIB) plus nonsteroidal aromatase inhibitor (NSAI) in patients (pts) with HR+/HER2− early breast cancer (EBC): NATALEE 5-year outcomes#LBA14
Proffered Paper session
October 17, 2025
14:00 – 15:30 CESTKisqali® (ribociclib)Impact of neoadjuvant chemotherapy (NACT) response on clinical outcomes with ribociclib (RIB) in HR+/HER2− EBC: a subgroup analysis from the phase 3 NATALEE trial#366P
Poster Presentation
October 20, 2025
09:00 – 17:00 CESTKisqali® (ribociclib)A NATALEE data–based machine learning (ML) model to predict distant recurrence (DR) and treatment (tx) effect in real-world (RW) patients (pts) with HR+/HER2– early breast cancer (EBC) without CDK4/6 inhibitor (CDK4/6i) tx#372P
Poster Presentation
October 20, 2025
09:00 – 17:00 CESTKisqali® (ribociclib)Real-world characteristics, treatments and outcomes of NATALEE and monarchE-eligible HR+/HER2- early breast cancer patients in the hospital district of Helsinki and Uusimaa (HUS), Finland#360P
Poster Presentation
October 20, 2025
09:00 – 17:00 CESTKisqali® (ribociclib)Risk of Recurrence (ROR) After Neoadjuvant Ribociclib Plus ET in Clinically High-Risk ER+/HER2− BC: Preliminary Analysis of the SOLTI-RIBOLARIS Trial #296O
Proffered Paper session
October 17, 2025
14:00 – 15:30 CEST Novartis in oncology
The Novartis oncology strategy focuses on people living with cancer and those who care for them, from loved ones to clinical care teams, including their providers. For the past 30+ years, the aim has been to extend and improve lives by discovering differentiated, innovative and practice-changing medicines for patients.
As Novartis reimagines medicine, it collaborates with a wide range of patient advocacy groups and supports education, early cancer screening and diagnosis. With approximately 35 research and development projects across solid tumors, hematology and radioligand therapy (RLT), Novartis is committed to using technology, leading science and patient-centered research to deliver pioneering cancer care for all those in need.
Disclaimer
This press release contains forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements can generally be identified by words such as “potential,” “can,” “will,” “plan,” “may,” “could,” “would,” “expect,” “anticipate,” “look forward,” “believe,” “committed,” “investigational,” “pipeline,” “launch,” or similar terms, or by express or implied discussions regarding potential marketing approvals, new indications or labeling for the investigational or approved products described in this press release, or regarding potential future revenues from such products. You should not place undue reliance on these statements. Such forward-looking statements are based on our current beliefs and expectations regarding future events, and are subject to significant known and unknown risks and uncertainties. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those set forth in the forward-looking statements. There can be no guarantee that the investigational or approved products described in this press release will be submitted or approved for sale or for any additional indications or labeling in any market, or at any particular time. Nor can there be any guarantee that such products will be commercially successful in the future. In particular, our expectations regarding such products could be affected by, among other things, the uncertainties inherent in research and development, including clinical trial results and additional analysis of existing clinical data; regulatory actions or delays or government regulation generally; global trends toward health care cost containment, including government, payor and general public pricing and reimbursement pressures and requirements for increased pricing transparency; our ability to obtain or maintain proprietary intellectual property protection; the particular prescribing preferences of physicians and patients; general political, economic and business conditions, including the effects of and efforts to mitigate pandemic diseases; safety, quality, data integrity or manufacturing issues; potential or actual data security and data privacy breaches, or disruptions of our information technology systems, and other risks and factors referred to in Novartis AG’s current Form 20-F on file with the US Securities and Exchange Commission. Novartis is providing the information in this press release as of this date and does not undertake any obligation to update any forward-looking statements contained in this press release as a result of new information, future events or otherwise.
About Novartis
Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach nearly 300 million people worldwide.
Reimagine medicine with us: Visit us at https://www.novartis.com and connect with us on LinkedIn, Facebook, X/Twitter and Instagram.
Analyst’s Disclosure:I/we have a beneficial long position in the shares of IONQ, QBTS either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it. I have no business relationship with any company whose stock is mentioned in this article.
This transcription was created from a CEF Insights podcast recorded in September 2025. For more information, please visit cefa.com. This material is not and is not intended as investment advice, an indication of trading intent or holdings or the prediction of investment performance. All fund-specific information is the latest publicly available information. All other information is current as of the date of this presentation. All opinions and forward-looking statements are subject to change at any time.
Western Asset Management disclaims any responsibility to update such views and/or information. This information is deemed to be from reliable sources; however, Western Asset does not warrant its completeness or accuracy. This presentation is not intended to, and does not constitute an offer or solicitation to sell or a solicitation of an offer to buy any security, product, investment advice or service (nor shall any security, product, investment advice or service be offered or sold) in any jurisdiction in which Western Asset is not licensed to conduct business, and/or an offer, solicitation, purchase or a sale would be unavailable or unlawful.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
London, 26 September 2025 – Endeavour Mining plc (LSE:EDV, TSX:EDV) (“the Company”) announces it has purchased the following number of its ordinary shares of USD 0.01 each from Stifel Nicolaus Europe Limited.
Aggregated information
Dates of purchase:25 September 2025Aggregate number of ordinary shares of USD 0.01 each purchased:12,500Lowest price paid per share (GBp): 3,010.00Highest price paid per share (GBp): 3,062.00Volume weighted average price paid per share (GBp): 3,041.44 Following the cancellation of the repurchased shares, the Company will have no ordinary shares in treasury and 241,400,212 ordinary shares in issue. Therefore the total voting rights in the Company will be 241,400,212. This figure for the total number of voting rights may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.
These share purchases form part of the Company's buy-back programme announced on 20 March 2025.
Transaction details
In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation), the table below contains detailed information of the individual trades made by Stifel Nicolaus Europe Limited as part of the buyback programme.
For Investor Relations Enquiries:For Media Enquiries:Jack GarmanBrunswick Group LLP in LondonVice President of Investor RelationsCarole Cable, Partner+44 203 011 2723+ 44 207 404 [email protected]@brunswickgroup.com ABOUT ENDEAVOUR MINING PLC
Endeavour Mining is one of the world’s senior gold producers and the largest in West Africa, with operating assets across Senegal, Cote d’Ivoire and Burkina Faso and a strong portfolio of advanced development projects and exploration assets in the highly prospective Birimian Greenstone Belt across West Africa.
A member of the World Gold Council, Endeavour is committed to the principles of responsible mining and delivering sustainable value to its employees, stakeholders and the communities where it operates. Endeavour is admitted to listing and to trading on the London Stock Exchange and the Toronto Stock Exchange, under the symbol EDV.
For more information, please visit www.endeavourmining.com.
CAUTIONARY NOTE REGARDING FORWARD-LOOKING INFORMATION
This news release contains "forward-looking statements" within the meaning of applicable securities laws. All statements, other than statements of historical fact, are "forward-looking statements". Generally, these forward-looking statements can be identified by the use of forward-looking terminology such as "expects", "expected", "budgeted", "forecasts", and "anticipates".
Forward-looking statements, while based on management's best estimates and assumptions, are subject to risks and uncertainties that may cause actual results to be materially different from those expressed or implied by such forward-looking statements, including but not limited to: risks related to the successful integration of acquisitions; risks related to international operations; risks related to general economic conditions and credit availability, actual results of current exploration activities, unanticipated reclamation expenses; changes in project parameters as plans continue to be refined; fluctuations in prices of metals including gold; fluctuations in foreign currency exchange rates, increases in market prices of mining consumables, possible variations in ore reserves, grade or recovery rates; failure of plant, equipment or processes to operate as anticipated; accidents, labour disputes, title disputes, claims and limitations on insurance coverage and other risks of the mining industry; delays in the completion of development or construction activities, changes in national and local government regulation of mining operations, tax rules and regulations, and political and economic developments in countries in which Endeavour operates. Although Endeavour has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. Please refer to Endeavour's most recent Annual Information Form filed under its profile at www.sedarplus.ca for further information respecting the risks affecting Endeavour and its business.
Transaction in own shares
2025-09-26 06:545mo ago
2025-09-26 01:445mo ago
HubSpot: Plenty Of Drivers In Place To Grow The Business
SummaryHubSpot remains a buy, driven by strong AI execution, rapid Core Seat adoption, and accelerating multi-hub usage.HUBS's AI strategy, including "The Loop" and Data Hub, positions customers for success in the evolving Agent Engine Optimization (AEO) landscape.The new seat-based pricing model increases user penetration and embeds HUBS deeper into organizations, fueling robust ARR growth. MoMo Productions/DigitalVision via Getty Images
Investment action I had a buy rating for HubSpot (NYSE:HUBS) previously, as I believed it was in a great position to grow robustly, with support from the shift to seat-based pricing and AI monetization. The latest updates, particularly from INBOUND 2025, reinforce my
Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
Recommended For You
2025-09-26 06:545mo ago
2025-09-26 01:495mo ago
Mesoblast Cell Therapy Products are Designated U.S. Origin and Not Subject to Tariffs
NEW YORK, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today reiterated that its allogeneic cell therapy products are manufactured from U.S. donors in the U.S. and designated as U.S. origin products not subject to tariffs on imported branded or patented pharmaceutical products.
Ryoncil® (remestemcel-L) is the only allogeneic mesenchymal stromal cell therapy approved by U.S. Food and Drug Administration (FDA) for any indication. As documented in the Company’s Biologic License Application (BLA), Ryoncil® is designated a ‘U.S. Country of Origin’ product in line with U.S. FDA and Customs regulatory guidance.
Ryoncil® is approved for treatment of pediatric patients 2 months and older, including adolescents and teenagers, with steroid-refractory acute graft versus host disease (SR-aGvHD), a condition with high mortality rates.
Mesoblast continues to ensure that all its products, whether for SR-aGvHD, chronic heart failure, chronic back pain, or other inflammatory indications, are manufactured from U.S. donors at U.S. sites.
About Mesoblast
Mesoblast (the Company) is a world leader in developing allogeneic (off-the-shelf) cellular medicines for the treatment of severe and life-threatening inflammatory conditions. The therapies from the Company’s proprietary mesenchymal lineage cell therapy technology platform respond to severe inflammation by releasing anti-inflammatory factors that counter and modulate multiple effector arms of the immune system, resulting in significant reduction of the damaging inflammatory process.
Mesoblast’s Ryoncil® (remestemcel-L-rknd) for the treatment of steroid-refractory acute graft versus host disease (SR-aGvHD) in pediatric patients 2 months and older is the first FDA-approved mesenchymal stromal cell (MSC) therapy. Please see the full Prescribing Information at www.ryoncil.com.
Mesoblast is committed to developing additional cell therapies for distinct indications based on its remestemcel-L and rexlemestrocel-L allogeneic stromal cell technology platforms. Ryoncil® is being developed for additional inflammatory diseases including SR-aGvHD in adults and biologic-resistant inflammatory bowel disease. Rexlemestrocel-L is being developed for heart failure and chronic low back pain. The Company has established commercial partnerships in Japan, Europe and China.
About Mesoblast intellectual property: Mesoblast has a strong and extensive global intellectual property portfolio, with over 1,000 granted patents or patent applications covering mesenchymal stromal cell compositions of matter, methods of manufacturing and indications. These granted patents and patent applications are expected to provide commercial protection extending through to at least 2041 in major markets.
About Mesoblast manufacturing: The Company’s proprietary manufacturing processes yield industrial-scale, cryopreserved, off-the-shelf, cellular medicines. These cell therapies, with defined pharmaceutical release criteria, are planned to be readily available to patients worldwide.
Mesoblast has locations in Australia, the United States and Singapore and is listed on the Australian Securities Exchange (MSB) and on the Nasdaq (MESO). For more information, please see www.mesoblast.com, LinkedIn: Mesoblast Limited and Twitter: @Mesoblast
Forward-Looking Statements
This press release includes forward-looking statements that relate to future events or our future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to differ materially from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. We make such forward-looking statements pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and other federal securities laws. Forward-looking statements should not be read as a guarantee of future performance or results, and actual results may differ from the results anticipated in these forward-looking statements, and the differences may be material and adverse. Forward-looking statements include, but are not limited to, statements about: the initiation, timing, progress and results of Mesoblast’s preclinical and clinical studies, and Mesoblast’s research and development programs; Mesoblast’s ability to advance product candidates into, enroll and successfully complete, clinical studies, including multi-national clinical trials; Mesoblast’s ability to advance its manufacturing capabilities; the timing or likelihood of regulatory filings and approvals, manufacturing activities and product marketing activities, if any; the commercialization of Mesoblast’s Ryoncil® for pediatric SR-aGVHD and any other product candidates, if approved; regulatory or public perceptions and market acceptance surrounding the use of stem-cell based therapies; the potential for Mesoblast’s product candidates, if any are approved, to be withdrawn from the market due to patient adverse events or deaths; the potential benefits of strategic collaboration agreements and Mesoblast’s ability to enter into and maintain established strategic collaborations; Mesoblast’s ability to establish and maintain intellectual property on its product candidates and Mesoblast’s ability to successfully defend these in cases of alleged infringement; the scope of protection Mesoblast is able to establish and maintain for intellectual property rights covering its product candidates and technology; estimates of Mesoblast’s expenses, future revenues, capital requirements and its needs for additional financing; Mesoblast’s financial performance; developments relating to Mesoblast’s competitors and industry; and the pricing and reimbursement of Mesoblast’s product candidates, if approved. You should read this press release together with our risk factors, in our most recently filed reports with the SEC or on our website. Uncertainties and risks that may cause Mesoblast’s actual results, performance or achievements to be materially different from those which may be expressed or implied by such statements, and accordingly, you should not place undue reliance on these forward-looking statements. We do not undertake any obligations to publicly update or revise any forward-looking statements, whether as a result of new information, future developments or otherwise.
Release authorized by the Chief Executive.
For more information, please contact:
Corporate Communications / Investors Paul Hughes T: +61 3 9639 6036 Media – Global Allison Worldwide Emma Neal T: +1 603 545 4843 E: [email protected] Media – Australia BlueDot Media Steve Dabkowski T: +61 419 880 486 E: [email protected]
Gayathri Diwakar - Senior Director of Investor Relations
R. Struthers - Founder, President, CEO & Director
Dana Pizzuti - Chief Medical & Development Officer
Isabel Kalofonos - Chief Commercial Officer
Tobin Schilke - Chief Financial Officer
Alan Krasner - Chief Endocrinologist
Conference Call Participants
Joshua Schimmer - Cantor Fitzgerald & Co., Research Division
Yasmeen Rahimi - Piper Sandler & Co., Research Division
Gavin Clark-Gartner - Evercore ISI Institutional Equities, Research Division
Joseph Schwartz - Leerink Partners LLC, Research Division
Anthea Li - Jefferies LLC, Research Division
Catherine Okoukoni - Citizens JMP Securities, LLC, Research Division
Brian Skorney - Robert W. Baird & Co. Incorporated, Research Division
Cory Jubinville - LifeSci Capital, LLC, Research Division
Douglas Tsao - H.C. Wainwright & Co, LLC, Research Division
Catherine Novack - JonesTrading Institutional Services, LLC, Research Division
Presentation
Operator
Welcome to the Crinetics Pharmaceuticals PALSONIFY FDA Approval Conference Call. [Operator Instructions]
I will now turn the call over to Gayathri Diwakar, Head of Investor Relations. Please go ahead.
Gayathri Diwakar
Senior Director of Investor Relations
Thank you, operator. Good afternoon, everyone, and thank you for joining us to discuss the FDA approval of PALSONIFY. Today on the call, we have Dr. Scott Struthers, Founder and Chief Executive Officer; Dr. Dana Pizzuti, Chief Medical and Development Officer; and Isabel Kalofonos, Chief Commercial Officer. In addition, Tobin Schilke, Chief Financial Officer; and Dr. Alan Krasner, Chief Endocrinologist, will also be joining for the Q&A portion.
Please note, there is a slide deck for today's presentation, which is in the Events and Presentations section of the Investors page on the Crinetics website. In addition, a press release was issued earlier today and is also available on the corporate website.
Slide 2. As a reminder, we'll be making forward-looking statements, and I invite you to learn more about the risks and uncertainties associated with these
DIVERSIFIED ENERGY COMPANY PLC (LSE:DEC, NYSE:DEC) announces that, in accordance with the terms of its share buyback programme announced on 20 March 2025, the Company has purchased 15,062 Ordinary Shares of 20 Pence each in the capital of the Company (the "Shares") in the market at a volume-weighted average price of $14.3474 per Share through Mizuho Securities USA LLC (MSUSA). The Shares acquired will, in due course, be cancelled.
Aggregated Information
Date of Purchase:25 September 2025Aggregate Number of Ordinary Shares Purchased:15,062Lowest Price Paid per Share (USD):14.34Highest Price Paid per Share (USD):14.35Volume-Weighted Average Price Paid per Share (USD):14.3474
Following the cancellation of Shares, Diversified will have 77,419,017 Ordinary Shares of 20 Pence each in issue and no Ordinary Shares are held in treasury. This figure of 77,419,017 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.
In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation), (as in force in the UK and as amended by the Market Abuse (Amendment) (EU Exit) Regulations 2019), the table below contains detailed information of the individual trades made by Mizuho Securities USA LLC as part of the buyback programme.
Schedule of Purchases
Shares purchased:DIVERSIFIED ENERGY COMPANY PLC (ISIN: GB00BQHP5P93)Dates of purchases:25 September 2025Investment firm:Mizuho Securities USA LLC Aggregate
number of
ordinary
shares
acquiredDaily
volume
weighted
average
price paidDaily
highest
price paid
per shareDaily
lowest
price per
shareTrading
Venue500 $14.3467$14.35$14.34ARCX35 $14.3500$14.35$14.35ASPN865 $14.3499$14.35$14.35BAML1,022 $14.3496$14.35$14.35BARX200 $14.3500$14.35$14.35BATS700 $14.3450$14.35$14.35BIDS100 $14.3400$14.34$14.34EDGA87 $14.3500$14.35$14.35EDGX700 $14.3450$14.35$14.35ICBX4,888 $14.3480$14.35$14.34IEXG897 $14.3494$14.35$14.35JPMX1,200 $14.3488$14.35$14.35LEVL149 $14.3500$14.35$14.35SGMT1,750 $14.3488$14.35$14.35UBSA874 $14.3483$14.35$14.35VFMI100 $14.3500$14.35$14.35XBOS995 $14.3500$14.35$14.35XNASTrading venueCurrency NYSEUSD$14.347415,062
For further information, please contact:
Diversified Energy Company PLC+1 973 856 2757Doug [email protected] Vice President, Investor Relations & Corporate Communicationswww.div.energy
About Diversified Energy Company PLC
Diversified is a leading publicly traded energy company focused on natural gas and liquids production, transport, marketing, and well retirement. Through our differentiated strategy, we acquire existing, long-life assets and invest in them to improve environmental and operational performance until retiring those assets in a safe and environmentally secure manner. Recognized by ratings agencies and organizations for our sustainability leadership, this solutions-oriented, stewardship approach makes Diversified the Right Company at the Right Time to responsibly produce energy, deliver reliable free cash flow, and generate shareholder value.
Hydro's third quarter results 2025 will be released at 07:00 CEST (01:00 EDT, 06:00 BST, 05:00 UTC/GMT) on October 24, 2025. The quarterly report and presentation will be available on hydro.com at the same time as the release.
President and CEO Eivind Kallevik and Executive Vice President and CFO Trond Olaf Christophersen, will host a webinar in English at 08:30 CEST the same day. There will be a Q&A session directly after the presentation. There will be no physical presentation or press conference.
To join the webinar and ask questions, use the link to the webcast page.
The webcast is powered by Zoom. No login or registration in advance is required. It is also possible to log in using the dial-in option:
Norway +47 2400 4736
London, UK +44 330 088 5830
New York, US +1 929 205 6099
Find your local number
Meeting ID: 933 0129 2025
We advise you to investigate in advance if your company has any restrictions using the Zoom platform.
26 September 2025 – Alstom, global leader in smart and sustainable mobility, announces that it has received a ~€475m order from an undisclosed customer in Europe for the supply of rolling stock.
This order will be booked in Q2 FY 2025/26.
ALSTOM™ is a protected trademark of the Alstom Group.
Alstom Alstom commits to contribute to a low carbon future by developing and promoting innovative and sustainable transportation solutions that people enjoy riding. From high-speed trains, metros, monorails, trams, to turnkey systems, services, infrastructure, signalling and digital mobility, Alstom offers its diverse customers the broadest portfolio in the industry. With its presence in 63 countries and a talent base of over 86,000 people from 184 nationalities, the company focuses its design, innovation, and project management skills to where mobility solutions are needed most. Listed in France, Alstom generated sales of €18.5 billion for the fiscal year ending on 31 March 2025.
For more information, please visit www.alstom.com. Contacts Investor Relations
Cyril GUERIN - Tel.: +33 (0)6 07 89 36 16 [email protected]
, /PRNewswire/ -- Uxin Limited ("Uxin" or the "Company") (Nasdaq: UXIN), China's leading used car retailer, today announced that its new used car superstore in Zhengzhou, Henan Province will officially open on September 27, 2025.
The Zhengzhou used car superstore has a gross floor area of approximately 150,000 square meters, integrating one of China's largest used-car showrooms with an in-house reconditioning facility. The site is designed to accommodate up to 5,000 vehicles for display and sale. Following the Company's successful launch of superstores in Xi'an, Hefei, and Wuhan, Zhengzhou marks Uxin's fourth superstore, underscoring the Company's ability to replicate and scale its business model across major Chinese cities.
Zhengzhou is the capital city of Henan Province, which is one of China's most populous provinces. The city has a resident population exceeding 13 million and over 5 million registered vehicles. Zhengzhou ranks among the top ten cities nationwide in used car transactions and serves as the key transportation hub in central China, providing strong fundamentals to support the operation of a large-scale used car superstore.
With the opening of the Zhengzhou superstore, Uxin is set to deliver a wider selection of high-quality vehicles and professional services to regional consumers, while significantly expanding its market penetration in central China. The continued rollout of new superstores is expected to be a key growth driver of Uxin's sales volume and financial performance in the coming years.
About Uxin
Uxin is China's leading used car retailer, pioneering industry transformation with advanced production, new retail experiences, and digital empowerment. We offer high-quality and value-for-money vehicles as well as superior after-sales services through a reliable, one-stop, and hassle-free transaction experience. Under our omni-channel strategy, we are able to leverage our pioneering online platform to serve customers nationwide and establish market leadership in selected regions through offline superstores with inventory capacities ranging from 2,000 to 8,000 vehicles. Leveraging our extensive industry data and continuous technology innovation throughout more than ten years of operation, we have established strong used car management and operation capabilities. We are committed to upholding our customer-centric approach and driving the healthy development of China's used car industry.
Safe Harbor Statement
This press release contains statements that may constitute "forward-looking" statements which are made pursuant to the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will," "expects," "anticipates," "aims," "future," "intends," "plans," "believes," "estimates," "likely to," and similar statements. Statements that are not historical facts, including statements about Uxin's beliefs, plans, and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: the risk and uncertainties as to the timing of the entry into definitive agreements or consummation of the transactions; the risk that certain closing conditions of the transactions may not be satisfied on a timely basis, or at all; impact of the COVID-19 pandemic; Uxin's goal and strategies; its expansion plans and successful completion of certain financing transactions; its future business development, financial condition and results of operations; Uxin's expectations regarding demand for, and market acceptance of, its services; its ability to provide differentiated and superior customer experience, maintain and enhance customer trust in its platform, and assess and mitigate various risks, including credit; its expectations regarding maintaining and expanding its relationships with business partners, including financing partners; trends and competition in China's used car e-commerce industry; the laws and regulations relating to Uxin's industry; the general economic and business conditions; and assumptions underlying or related to any of the foregoing.
For investor and media enquiries, please contact:
Uxin Limited Investor Relations
Uxin Limited
Email: [email protected]
The Blueshirt Group
Mr. Jack Wang
Phone: +86 166-0115-0429
Email: [email protected]
SOURCE Uxin Limited
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
440k+
Newsrooms &
Influencers
9k+
Digital Media
Outlets
270k+
Journalists
Opted In
2025-09-26 06:545mo ago
2025-09-26 02:025mo ago
OPEC+ is poised to slip further below oil output target
SummaryOPEC+ has failed to hit its increased targetsSome members struggle to raise outputSome face curbs because of previous overproductionOPEC+ may deliver only half of next output hikesLONDON, Sept 26 (Reuters) - OPEC+ has delivered about three quarters of the extra oil output it targeted since the group started production hikes in April, and the level may fall closer to half later in the year as producers hit capacity limits, sources and analysts said and data showed.
OPEC+, which produces 50% of global oil and brings together the Organization of the Petroleum Exporting Countries and allies such as Russia, has been pumping almost 500,000 barrels per day below its targets. The shortfall, equal to 0.5% of global demand, has defied market expectations of a supply glut and supported oil prices.
Sign up here.
Eight members of OPEC+ that introduced voluntary oil output cuts in April 2023 to support the market began raising output this April. OPEC+ total reductions - voluntary and for the whole group - amounted at their peak to 5.85 million bpd in three different layers.
The eight plan to fully unwind their most recent round of cuts - 2.2 million bpd - by the end of September and start removing a second layer of 1.65 million bpd in October. OPEC+ gave the United Arab Emirates approval to boost production by 0.3 million bpd between April and September.
ALMOST 500,000 BARRELS PER DAY BELOW TARGETBetween April and August, OPEC+ delivered only 75% of production increases, according to a Reuters analysis of OPEC+ data, producing almost 500,000 bpd below the targeted increase of 1.92 million bpd for that period.
Data beyond August is not yet available.
The OPEC+ have only delivered about three quarters of their agreed target increases in April-August as some countries compensated for overproduction and some struggled with capacity.This shortfall has helped to keep Brent crude prices near a seven-week high of $69 per barrel. OPEC+'s constraints are one factor supporting prices, analysts at Barclays and Kpler said this month.
Analysts have yet to revise oil price forecasts.
Brent's immediate delivery price rose this week to a $2.39 premium over six-month futures , the highest since early August, indicating a perception that immediate supplies are limited.
"The futures curve... is indicating market tightness, which is in contrast to observers claiming there's a glut," said Giovanni Staunovo of UBS, who is sticking with his latest price forecasts.
MOST CANNOT PUMP MORETwo main factors explain the shortfall. Firstly, OPEC+ told members including Kazakhstan and Iraq to make extra cuts, called compensation cuts, for previously exceeding agreed levels.
Secondly, the group faces dwindling spare production capacity - idle output that could quickly come online - after years of low investment, said OPEC+ sources, industry executives and analysts.
One OPEC+ delegate, who declined to be named because of the sensitivity of the matter, said most member countries cannot produce more.
The International Energy Agency put OPEC+ spare capacity at 4.1 million bpd as of August. But almost all of that is held by Saudi Arabia and the UAE, said an industry source who regularly buys oil from multiple OPEC+ producers.
OPEC+ spare capacity and government oil stocks in the West and China serve as the world’s primary buffers against supply disruptions from wars or natural disasters.
Perceptions of falling spare capacity often unsettle markets, especially when OPEC+ raises production.
SEPTEMBER, OCTOBER HIKESOPEC+ is due to raise production by 547,000 bpd in September and a further 137,000 bpd in October.
Data for those months is not yet available but actual production increases will likely represent only half of targets, analysts said.
OPEC+ members Algeria, Kazakhstan, Oman and Russia are already producing near capacity, said Homayoun Falakshahi, head of crude oil analysis at Kpler.
The group is able to increase real production only by 0.7-0.8 million bpd if it decides to fully unwind the second layer of cuts of 1.65 million bpd, Falakshahi said.
OPEC+ will begin unwinding the second layer of cuts in October with a small increase in targets by 137,000 bpd.
The group will likely fall short and the real production boost will not exceed 70,000 bpd, analysts at RBC Capital said.
Saudi crude output in August was 747,000 bpd higher than in March, accounting for more than half of the cumulative OPEC+ increase between April and August, the OPEC data showed.
The OPEC+ 8 were only able to meet their target increases in June and August so far.Unused capacity is set to diminish further into next year. Barclays predicts OPEC spare capacity will fall to 2 million bpd by September 2026. OPEC+ still has in place its third group-wide layer of cuts of 2 million bpd until end-2026.
Reporting by Seher Dareen and Ahmad Ghaddar in London, editing by Alex Lawler, Dmitry Zhdannikov, Simon Webb and Barbara Lewis
Our Standards: The Thomson Reuters Trust Principles., opens new tab
Seher oversees and writes market reports with the commodities and energy team in Bangalore round-the-clock and monitors newsworthy events in the resources space.
2025-09-26 06:545mo ago
2025-09-26 02:115mo ago
Commerzbank share price on edge after new UniCredit report
Commerzbank share price has pulled back from its highest point this year as investors wait for more information from UniCredit. The CBK stock was trading at €32.7 on Friday, down from the year-to-date high of €38.3.
2025-09-26 06:545mo ago
2025-09-26 02:185mo ago
Italy's antitrust fines Eni and other oil firms for unfair competition
The logo of Italian multinational energy company Eni is displayed at their booth during the LNG 2023 energy trade show in Vancouver, British Columbia, Canada, July 12, 2023. REUTERS/Chris Helgren/File Photo Purchase Licensing Rights, opens new tab
CompaniesROME, Sept 26 (Reuters) - Italy's antitrust regulator said on Friday it had fined Italian energy major Eni
(ENI.MI), opens new tab and five other oil companies operating in the country for practices restricting fair competition in the sale of fuel for trucks.
The antitrust body said the fines totaled more than 936 million euros ($1.09 billion) and had been levied against Eni, Esso, Ip, Q8, Saras and Tamoil.
Sign up here.
($1 = 0.8562 euros)
Reporting by Gavin Jones, editing by Alvise Armellini
Our Standards: The Thomson Reuters Trust Principles., opens new tab
2025-09-26 06:545mo ago
2025-09-26 02:265mo ago
Seeing Machines signs five-year deal with UK bus maker ahead of new EU safety rules
Seeing Machines Ltd (AIM:SEE, OTC:SEEMF) has struck a five-year supply agreement with a UK bus manufacturer that will see its driver monitoring technology installed on thousands of vehicles across Europe, ahead of the introduction of stricter safety rules.
The London-listed company, which develops artificial intelligence systems to track driver alertness, said its Guardian Generation 3 system will be fitted at the factory on new buses destined for European markets.
The tie-up builds on around 200 vehicles the bus maker has already fitted with the kit. The manufacturer produces more than 1,700 buses a year.
The move comes as the European Union prepares to enforce its General Safety Regulation. From July 2026, new buses, lorries and other heavy vehicles will need to include technology to detect driver distraction and warn of potential accidents.
Seeing Machines is also working with four other vehicle makers in Europe on regulatory approvals, known as homologation, that could cover more than 4,000 vehicles a year.
Homologation is the process by which a vehicle is certified to meet the required safety standards across an entire model range.
Beyond bus manufacturing, the company is advancing talks with a large oil and gas operator on a contract to expand Guardian across its European fleet. The system is already in use with this customer in the UK and four other European countries.
Paul McGlone, chief executive of Seeing Machines, said: “This agreement is a major step for Seeing Machines as we expand our Guardian Generation 3 technology across Europe, supporting our partners to meet the highest safety standards ahead of the GSR deadline.
"Our growing collaborations with OEMs and industry leaders not only demonstrate the value of our AI-powered safety technology but also reflect Europe's strong commitment to protecting road users.”
2025-09-26 06:545mo ago
2025-09-26 02:285mo ago
Norwegian Air to buy an additional 30 Boeing 737 aircraft
The logo of Boeing company is displayed at the Australian International Airshow in Avalon, Australia March 26, 2025. REUTERS/Hollie Adams/File Photo Purchase Licensing Rights, opens new tab
COPENHAGEN, Sept 26 (Reuters) - Norwegian Air Shuttle
(NAS.OL), opens new tab said on Friday it had exercised an option to buy an additional 30 Boeing 737 MAX 8, bringing its total firm order to 80 aircraft.
"This milestone aircraft order is on attractive terms and secures our fleet growth in a way that supports our planned growth and sustainability targets," CEO Geir Karlsen said in a statement.
Sign up here.
The airline confirmed the final aircraft delivery is now scheduled for 2031, following adjustments to the delivery timeline. It initially announced the deal for 50 aircraft in 2022.
Reporting by Stine Jacobsen, editing by Terje Solsvik
Our Standards: The Thomson Reuters Trust Principles., opens new tab
2025-09-26 06:545mo ago
2025-09-26 02:295mo ago
Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Edwards Lifesciences Corporation - EW
, /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, continues to investigate potential breaches of fiduciary duties by the directors and officers of Edwards Lifesciences Corporation (NYSE: EW).
If you currently own shares of Edwards stock, please visit the firm's website at https://rosenlegal.com/submit-form/?case_id=29704 for more information. You may also contact Phillip Kim of Rosen Law Firm toll free at 866-767-3653 or via email at [email protected].
Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information:
Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
[email protected]
www.rosenlegal.com
SOURCE THE ROSEN LAW FIRM, P. A.
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
440k+
Newsrooms &
Influencers
9k+
Digital Media
Outlets
270k+
Journalists
Opted In
2025-09-26 06:545mo ago
2025-09-26 02:305mo ago
CSL Vifor and Travere Therapeutics Recognize Updated KDIGO Clinical Practice Guidelines for IgA Nephropathy
FILSPARI® (sparsentan) suggested for IgA Nephropathy patients who are at risk of progressive kidney function loss ST. GALLEN, Switzerland, and SAN DIEGO , Sept.